Differential	O
regulation	O
of	O
the	O
Janus	B-protein
kinase	I-protein
-STAT	B-protein
pathway	O
and	O
biologic	O
function	O
of	O
IL-13	B-protein
in	O
primary	B-cell_type
human	I-cell_type
NK	I-cell_type
and	I-cell_type
T	I-cell_type
cells	I-cell_type
:	O
a	O
comparative	O
study	O
with	O
IL-4	B-protein
.	O

IL-13	B-protein
,	O
a	O
cytokine	O
similar	O
to	O
IL-4	B-protein
,	O
is	O
a	O
regulator	O
of	O
human	O
B	O
cell	O
and	O
monocyte	O
functions	O
.	O

Biologic	O
effects	O
of	O
IL-13	B-protein
on	O
primary	B-cell_type
human	I-cell_type
NK	I-cell_type
and	I-cell_type
T	I-cell_type
cells	I-cell_type
have	O
not	O
been	O
well	O
defined	O
.	O

We	O
demonstrate	O
that	O
,	O
in	O
primary	B-cell_type
NK	I-cell_type
cells	I-cell_type
,	O
IL-13	B-protein
,	O
but	O
not	O
IL-4	B-protein
,	O
may	O
induce	O
low	O
levels	O
of	O
IFN-gamma	B-protein
secretion	O
.	O

When	O
NK	B-cell_type
cells	I-cell_type
were	O
costimulated	O
with	O
IL-13	B-protein
and	O
IL-2	B-protein
,	O
IL-13	B-protein
generally	O
resulted	O
in	O
two	O
types	O
of	O
reactivity	O
:	O
IL-13	B-protein
synergized	O
with	O
IL-2	B-protein
to	O
stimulate	O
IFN-gamma	B-protein
production	O
or	O
it	O
modestly	O
inhibited	O
IL-2	B-protein
-mediated	O
IFN-gamma	B-protein
production	O
.	O

In	O
both	O
types	O
of	O
donors	O
,	O
the	O
effect	O
of	O
IL-13	B-protein
on	O
IL-2	B-protein
-induced	O
IFN-gamma	B-protein
production	O
was	O
in	O
marked	O
contrast	O
to	O
the	O
strong	O
inhibition	O
seen	O
with	O
IL-4	B-protein
in	O
NK	B-cell_type
cells	I-cell_type
.	O

Additionally	O
,	O
IL-13	B-protein
suppresses	O
IL-2-induced	O
NK	O
cytolytic	O
and	O
proliferative	O
activities	O
although	O
less	O
efficiently	O
than	O
IL-4	B-protein
.	O

In	O
T	B-cell_type
cells	I-cell_type
,	O
IL-13	B-protein
inhibits	O
anti-CD3	O
mAb/IL-2-	O
or	O
PHA-mediated	O
IFN-gamma	O
production	O
and	O
enhances	O
cytolytic	O
potential	O
.	O

Furthermore	O
,	O
we	O
demonstrate	O
that	O
IL-13	B-protein
,	O
like	O
IL-4	B-protein
,	O
induces	O
distinct	O
STAT6-DNA	B-protein
binding	I-protein
complexes	I-protein
and	O
tyrosine	O
phosphorylation	O
of	O
STAT6	B-protein
and	O
Janus	B-protein
kinase	I-protein
3	I-protein
(	O
JAK3	B-protein
)	O
in	O
NK	O
and	O
T	B-cell_type
cells	I-cell_type
.	O

We	O
observed	O
that	O
Abs	O
directed	O
against	O
unique	O
domains	O
of	O
STAT6	B-protein
have	O
differential	O
effects	O
on	O
complexes	O
in	O
T	B-cell_type
cells	I-cell_type
but	O
not	O
in	O
NK	B-cell_type
cells	I-cell_type
,	O
suggesting	O
different	O
STAT6	B-protein
isoforms	I-protein
.	O

These	O
findings	O
show	O
that	O
IL-13	B-protein
and	O
IL-4	B-protein
have	O
the	O
ability	O
to	O
regulate	O
NK	O
and	O
T	O
cell	O
activation	O
and	O
that	O
IL-13	B-protein
is	O
a	O
potent	O
regulator	O
of	O
STAT6	B-protein
and	O
JAK3	B-protein
in	O
these	O
cell	O
types	O
.	O

C	NULL
%	NULL
Flexible	NULL
,	NULL
Intuitive	NULL
,	NULL
and	NULL
Luminex	NULL
.	NULL

C	NULL
$	NULL
3	NULL
Affordable	NULL
Cytometry	NULL
.	NULL

|	NULL
complexity	NULL
simplified	NULL
.	NULL

Guava®	NULL
easyCyte	NULL
``	NULL
Flow	NULL
Cytometers	NULL
.	NULL

s	NULL
teJournal	NULL
f	NULL
Differential	NULL
Regulation	NULL
of	NULL
the	NULL
Janus	NULL
Kinase-STAT	NULL
®	NULL
Imnmunolo	NULL
gy	NULL
Pathway	NULL
and	NULL
Biologic	NULL
Function	NULL
of	NULL
IL-13	NULL
in	NULL
Primary	NULL
Human	NULL
NK	NULL
and	NULL
T	NULL
Cells	NULL
:	NULL
A	NULL
Comparative	NULL
Study	NULL
with	NULL
IL-4	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Cheng-Rong	NULL
Yu	NULL
,	NULL
Robert	NULL
A.	NULL
Kirken	NULL
,	NULL
M.	NULL
Grazia	NULL
Malabarba	NULL
,	NULL
Howard	NULL
A	NULL
.	NULL

Young	NULL
and	NULL
John	NULL
R.	NULL
Ortaldo	NULL
J	NULL
Immunol	NULL
1998	NULL
;	NULL
161:218-227	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/1/218	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
64	NULL
articles	NULL
,	NULL
37	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/1/218.full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
Differential	NULL
Regulation	NULL
of	NULL
the	NULL
Janus	NULL
Kinase-STAT	NULL
Pathway	NULL
and	NULL
Biologic	NULL
Function	NULL
of	NULL
IL-13	NULL
in	NULL
Primary	NULL
Human	NULL
NK	NULL
and	NULL
T	NULL
Cells	NULL
:	NULL
A	NULL
Comparative	NULL
Study	NULL
with	NULL
IL-4	NULL
Cheng-Rong	NULL
Yu	NULL
,	NULL
*	NULL
Robert	NULL
A.	NULL
Kirken	NULL
,	NULL
*	NULL
M.	NULL
Grazia	NULL
Malabarba	NULL
,	NULL
'	NULL
Howard	NULL
A	NULL
.	NULL

Young	NULL
,	NULL
*	NULL
and	NULL
John	NULL
R.	NULL
Ortaldo'*	NULL
IL-13	NULL
,	NULL
a	NULL
cytokine	NULL
similar	NULL
to	NULL
IL-4	NULL
,	NULL
is	NULL
a	NULL
regulator	NULL
of	NULL
human	NULL
B	NULL
cell	NULL
and	NULL
monocyte	NULL
functions	NULL
.	NULL

Biologic	NULL
effects	NULL
of	NULL
IL-13	NULL
on	NULL
primary	NULL
human	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
have	NULL
not	NULL
been	NULL
well	NULL
defined	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
,	NULL
in	NULL
primary	NULL
NK	NULL
cells	NULL
,	NULL
IL-13	NULL
,	NULL
but	NULL
not	NULL
IL-4	NULL
,	NULL
may	NULL
induce	NULL
low	NULL
levels	NULL
of	NULL
IFN-y	NULL
secretion	NULL
.	NULL

When	NULL
NK	NULL
cells	NULL
were	NULL
costimulated	NULL
with	NULL
IL-13	NULL
and	NULL
IL-2	NULL
,	NULL
IL-13	NULL
generally	NULL
resulted	NULL
in	NULL
two	NULL
types	NULL
of	NULL
reactivity	NULL
:	NULL
IL-13	NULL
synergized	NULL
with	NULL
IL-2	NULL
to	NULL
stimulate	NULL
IFN-y	NULL
production	NULL
or	NULL
it	NULL
modestly	NULL
inhibited	NULL
IL-2-mediated	NULL
IFN-y	NULL
production	NULL
.	NULL

In	NULL
both	NULL
types	NULL
of	NULL
donors	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
IL-13	NULL
on	NULL
IL-2-induced	NULL
IFN-y	NULL
production	NULL
was	NULL
in	NULL
marked	NULL
contrast	NULL
to	NULL
the	NULL
strong	NULL
inhibition	NULL
seen	NULL
with	NULL
IL-4	NULL
in	NULL
NK	NULL
cells	NULL
.	NULL

Additionally	NULL
,	NULL
IL-13	NULL
suppresses	NULL
IL-2-induced	NULL
NK	NULL
cytolytic	NULL
and	NULL
proliferative	NULL
activities	NULL
although	NULL
less	NULL
efficiently	NULL
than	NULL
IL-4	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
,	NULL
IL-13	NULL
inhibits	NULL
anti-CD3	NULL
mAb/IL-2-	NULL
or	NULL
PHA-mediated	NULL
IFN-y	NULL
production	NULL
and	NULL
enhances	NULL
cytolytic	NULL
potential	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
IL-13	NULL
,	NULL
like	NULL
IL-4	NULL
,	NULL
induces	NULL
distinct	NULL
STAT6-DNA	NULL
binding	NULL
complexes	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT6	NULL
and	NULL
Janus	NULL
kinase	NULL
3	NULL
(	NULL
JAK3	NULL
)	NULL
in	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
Abs	NULL
directed	NULL
against	NULL
unique	NULL
domains	NULL
of	NULL
STAT6	NULL
have	NULL
differential	NULL
effects	NULL
on	NULL
complexes	NULL
in	NULL
T	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
NK	NULL
cells	NULL
,	NULL
suggesting	NULL
different	NULL
STAT6	NULL
isoforms	NULL
.	NULL

These	NULL
findings	NULL
show	NULL
that	NULL
IL-13	NULL
and	NULL
IL-4	NULL
have	NULL
the	NULL
ability	NULL
to	NULL
regulate	NULL
NK	NULL
and	NULL
T	NULL
cell	NULL
activation	NULL
and	NULL
that	NULL
IL-13	NULL
is	NULL
a	NULL
potent	NULL
regulator	NULL
of	NULL
STAT6	NULL
and	NULL
JAK3	NULL
in	NULL
these	NULL
cell	NULL
types	NULL
.	NULL

-	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1998	NULL
,	NULL
161	NULL
;	NULL
218-227.	NULL
blood	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
require	NULL
several	NULL
extracellular	NULL
signaling	NULL
proteins	NULL
,	NULL
including	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-12	NULL
,	NULL
and	NULL
IFNs	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

IL-13	NULL
is	NULL
a	NULL
13-kDa	NULL
protein	NULL
derived	NULL
from	NULL
activated	NULL
T	NULL
cells	NULL
and	NULL
mast	NULL
cells	NULL
.	NULL

Its	NULL
amino	NULL
acid	NULL
sequence	NULL
is	NULL
approximated	NULL
30	NULL
%	NULL
identity	NULL
to	NULL
that	NULL
of	NULL
IL-4	NULL
,	NULL
including	NULL
two	NULL
disulfide	NULL
linkages	NULL
(	NULL
4-6	NULL
)	NULL
.	NULL

IL-13	NULL
,	NULL
like	NULL
IL-4	NULL
,	NULL
has	NULL
been	NULL
found	NULL
to	NULL
have	NULL
a	NULL
critical	NULL
role	NULL
for	NULL
modulating	NULL
the	NULL
biologic	NULL
activity	NULL
of	NULL
human	NULL
B	NULL
lymphocytes	NULL
and	NULL
monocytes	NULL
.	NULL

For	NULL
example	NULL
,	NULL
IL-13	NULL
can	NULL
enhance	NULL
the	NULL
expression	NULL
of	NULL
MHC	NULL
II	NULL
and	NULL
CD23	NULL
in	NULL
monocytes	NULL
and	NULL
B	NULL
cells	NULL
and	NULL
induces	NULL
Ig	NULL
class	NULL
switching	NULL
to	NULL
IgE	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
with	NULL
IL-4	NULL
treatment	NULL
(	NULL
4-12	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
biologic	NULL
effects	NULL
of	NULL
IL-13	NULL
on	NULL
primary	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
have	NULL
not	NULL
been	NULL
well	NULL
defined	NULL
.	NULL

In	NULL
human	NULL
NK	NULL
cells	NULL
,	NULL
while	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
IL-13	NULL
,	NULL
unlike	NULL
IL-4	NULL
,	NULL
increases	NULL
IL-2-induced	NULL
IFN-y	NULL
production	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
and	NULL
cytolytic	NULL
activity	NULL
(	NULL
4	NULL
)	NULL
,	NULL
the	NULL
IL-13	NULL
signaling	NULL
mechanism	NULL
in	NULL
these	NULL
cells	NULL
has	NULL
not	NULL
been	NULL
investigated	NULL
.	NULL

In	NULL
human	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
biologic	NULL
effects	NULL
of	NULL
IL-13	NULL
have	NULL
not	NULL
been	NULL
fully	NULL
defined	NULL
although	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
IL-13	NULL
is	NULL
incapable	NULL
of	NULL
promoting	NULL
T	NULL
cell	NULL
proliferation	NULL
(	NULL
5	NULL
,	NULL
6	NULL
,	NULL
13	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
it	NULL
also	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
T	NULL
cells	NULL
(	NULL
5	NULL
,	NULL
13-15	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
NK	NULL
and	NULL
LAK	NULL
cells	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
,	NULL
lack	NULL
a	NULL
functional	NULL
IL-13R	NULL
.	NULL

P	NULL
I	NULL
I	NULL
he	NULL
activation	NULL
and	NULL
differentiation	NULL
of	NULL
human	NULL
peripheral	NULL
*Laboratory	NULL
of	NULL
Experimental	NULL
Immunology	NULL
,	NULL
*Laboratory	NULL
of	NULL
Molecular	NULL
Immunoregu-lation	NULL
,	NULL
Division	NULL
of	NULL
Basic	NULL
Sciences	NULL
;	NULL
*Intramural	NULL
Research	NULL
Support	NULL
Program	NULL
,	NULL
Science	NULL
Applications	NULL
International	NULL
Corporation-Frederick	NULL
;	NULL
National	NULL
Cancer	NULL
Institute-Prederick	NULL
Cancer	NULL
Research	NULL
and	NULL
Development	NULL
Center	NULL
,	NULL
Frederick	NULL
,	NULL
MD	NULL
21702	NULL
Received	NULL
for	NULL
publication	NULL
September	NULL
9	NULL
,	NULL
1997	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
March	NULL
3	NULL
,	NULL
1998	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
John	NULL
R.	NULL
Ortaldo	NULL
,	NULL
National	NULL
Cancer	NULL
Institute-Prederick	NULL
Cancer	NULL
Research	NULL
and	NULL
Development	NULL
Center	NULL
,	NULL
Building	NULL
560	NULL
,	NULL
Room	NULL
31-93	NULL
,	NULL
Frederick	NULL
,	NULL
MD	NULL
21702	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
Ortaldo	NULL
@	NULL
nciferf.gov	NULL
2	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
LAK	NULL
,	NULL
lymphokine	NULL
activated	NULL
killer	NULL
;	NULL
GAS	NULL
,	NULL
IFN-y	NULL
activated	NULL
sequence	NULL
;	NULL
JAK	NULL
,	NULL
Janus	NULL
kinase	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
;	NULL
PHA	NULL
,	NULL
phytohemagglutinin	NULL
;	NULL
PE	NULL
,	NULL
phycoerythrin	NULL
;	NULL
SIB	NULL
,	NULL
sis-inducible	NULL
element	NULL
.	NULL

Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
In	NULL
contrast	NULL
,	NULL
it	NULL
also	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
IL-13	NULL
,	NULL
like	NULL
IL-4	NULL
,	NULL
induces	NULL
IL-4	NULL
responsive	NULL
element	NULL
DNA	NULL
protein	NULL
complexes	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
16	NULL
)	NULL
and	NULL
FoyRI	NULL
GAS	NULL
promoter	NULL
DNA	NULL
protein	NULL
binding	NULL
complexes	NULL
in	NULL
fresh	NULL
human	NULL
PBL	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
this	NULL
limited	NULL
information	NULL
suggests	NULL
that	NULL
the	NULL
biologic	NULL
effects	NULL
of	NULL
IL-13	NULL
might	NULL
be	NULL
distinct	NULL
when	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
are	NULL
compared	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
signaling	NULL
and	NULL
biologic	NULL
effects	NULL
of	NULL
IL-13	NULL
on	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
to	NULL
define	NULL
the	NULL
possible	NULL
different	NULL
effects	NULL
of	NULL
IL-13	NULL
on	NULL
these	NULL
cell	NULL
types	NULL
and	NULL
to	NULL
determine	NULL
whether	NULL
these	NULL
effects	NULL
are	NULL
distinct	NULL
from	NULL
those	NULL
of	NULL
IL-4	NULL
.	NULL

The	NULL
molecular	NULL
basis	NULL
for	NULL
cytokine	NULL
functional	NULL
redundancy	NULL
is	NULL
thought	NULL
to	NULL
occur	NULL
through	NULL
shared	NULL
receptor	NULL
chains	NULL
or	NULL
signaling	NULL
molecules	NULL
(	NULL
18	NULL
)	NULL
.	NULL

According	NULL
to	NULL
binding	NULL
assays	NULL
and	NULL
functional	NULL
analysis	NULL
,	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
IL-13	NULL
and	NULL
IL-4	NULL
share	NULL
common	NULL
signaling	NULL
molecule	NULL
(	NULL
s	NULL
)	NULL
(	NULL
6	NULL
,	NULL
12	NULL
,	NULL
19-24	NULL
)	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
,	NULL
IL-4Ra	NULL
conjugates	NULL
with	NULL
the	NULL
common	NULL
y-chain	NULL
(	NULL
cy	NULL
)	NULL
(	NULL
25	NULL
)	NULL
to	NULL
form	NULL
a	NULL
high	NULL
affinity	NULL
IL-4R	NULL
complex	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
human	NULL
and	NULL
murine	NULL
IL-13Ra	NULL
chains	NULL
,	NULL
responsible	NULL
for	NULL
binding	NULL
IL-13	NULL
,	NULL
were	NULL
cloned	NULL
and	NULL
found	NULL
capable	NULL
of	NULL
associating	NULL
with	NULL
the	NULL
IL-4Ra	NULL
to	NULL
form	NULL
a	NULL
high	NULL
affinity	NULL
IL-13	NULL
receptor	NULL
complex	NULL
(	NULL
28-30	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
IL-13	NULL
might	NULL
share	NULL
some	NULL
biologic	NULL
effects	NULL
with	NULL
IL-4	NULL
.	NULL

The	NULL
Janus	NULL
kinase	NULL
(	NULL
JAK	NULL
)	NULL
STAT	NULL
pathway	NULL
is	NULL
an	NULL
important	NULL
cyto-kine-induced	NULL
signal	NULL
transduction	NULL
pathway	NULL
that	NULL
directly	NULL
transfers	NULL
signals	NULL
from	NULL
cell	NULL
surface	NULL
cytokine	NULL
receptors	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
31-33	NULL
)	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
IL-4	NULL
,	NULL
IL-4Ra	NULL
and	NULL
cy	NULL
are	NULL
believed	NULL
to	NULL
be	NULL
associated	NULL
with	NULL
JAK1	NULL
and	NULL
JAK3	NULL
,	NULL
respectively	NULL
(	NULL
27	NULL
,	NULL
34	NULL
)	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
JAKs	NULL
leads	NULL
to	NULL
phosphorylation	NULL
of	NULL
IL-4Ra	NULL
and	NULL
recruitment	NULL
and	NULL
activation	NULL
of	NULL
STAT6	NULL
(	NULL
21	NULL
,	NULL
35-40	NULL
)	NULL
.	NULL

STAT6	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
regulating	NULL
the	NULL
expression	NULL
of	NULL
MHC	NULL
II	NULL
,	NULL
CD23	NULL
molecules	NULL
,	NULL
and	NULL
production	NULL
of	NULL
IgE	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
as	NULL
well	NULL
as	NULL
secretion	NULL
of	NULL
IL-4	NULL
and	NULL
IFN-y	NULL
in	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
STAT6-deficient	NULL
mouse	NULL
model	NULL
(	NULL
41-43	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
STAT	NULL
6	NULL
is	NULL
a	NULL
key	NULL
event	NULL
for	NULL
IL-4-mediated	NULL
biologic	NULL
effects	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
further	NULL
investigated	NULL
whether	NULL
or	NULL
not	NULL
STAT6	NULL
and	NULL
JAK3	NULL
were	NULL
involved	NULL
in	NULL
the	NULL
IL-13-induced	NULL
signal	NULL
transduction	NULL
in	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

0022-1767/98/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
IL-13	NULL
is	NULL
able	NULL
to	NULL
differentially	NULL
modulate	NULL
specific	NULL
biologic	NULL
properties	NULL
of	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
,	NULL
including	NULL
IFN-y	NULL
production	NULL
,	NULL
cytotoxic	NULL
activity	NULL
,	NULL
and	NULL
NK	NULL
cell	NULL
proliferation	NULL
,	NULL
and	NULL
that	NULL
these	NULL
effects	NULL
are	NULL
distinctive	NULL
from	NULL
those	NULL
mediated	NULL
by	NULL
IL-4	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
found	NULL
that	NULL
IL-13	NULL
induces	NULL
distinct	NULL
activation	NULL
of	NULL
STAT6	NULL
when	NULL
primary	NULL
human	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
are	NULL
compared	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
IL-13	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
regulating	NULL
the	NULL
differentiation	NULL
and	NULL
activation	NULL
of	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Medium	NULL
,	NULL
Abs	NULL
,	NULL
cytokines	NULL
,	NULL
and	NULL
reagents	NULL
Cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
(	NULL
BioWhittaker	NULL
,	NULL
Walkersville	NULL
,	NULL
MD	NULL
)	NULL
and	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
(	NULL
Atlanta	NULL
Biologic	NULL
,	NULL
Atlanta	NULL
,	NULL
GA	NULL
)	NULL
,	NULL
100	NULL
U/ml	NULL
penicillin	NULL
and	NULL
100	NULL
pg/ml	NULL
streptomycin	NULL
(	NULL
Biofluids	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Recom-binant	NULL
human	NULL
IL-2	NULL
was	NULL
provided	NULL
by	NULL
Chiron	NULL
(	NULL
Emeryville	NULL
,	NULL
Ca	NULL
)	NULL
,	NULL
and	NULL
IL-4	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
IL-13	NULL
were	NULL
purchased	NULL
from	NULL
Pepro	NULL
Tech	NULL
(	NULL
Rocky	NULL
Hill	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

IL-12	NULL
was	NULL
provided	NULL
by	NULL
Hoffmann-La	NULL
Roche	NULL
(	NULL
Nutley	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Antisera	NULL
against	NULL
STAT1la	NULL
,	NULL
STAT3	NULL
,	NULL
STATS5a	NULL
,	NULL
and	NULL
STAT5b	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
Andrew	NULL
C.	NULL
Larner	NULL
(	NULL
Food	NULL
and	NULL
Drug	NULL
Administration	NULL
,	NULL
Center	NULL
for	NULL
Biologics	NULL
Evaluation	NULL
and	NULL
Research	NULL
(	NULL
CBER	NULL
)	NULL
,	NULL
Division	NULL
of	NULL
Cytokine	NULL
Biology	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Antisera	NULL
to	NULL
STAT4	NULL
,	NULL
human	NULL
STAT6	NULL
(	NULL
residues	NULL
828-847	NULL
,	NULL
Cat	NULL
:	NULL
S-20	NULL
,	NULL
denoted	NULL
as	NULL
STAT6h1	NULL
)	NULL
,	NULL
and	NULL
mouse	NULL
STAT6	NULL
(	NULL
residues	NULL
280-480	NULL
,	NULL
Cat	NULL
:	NULL
M-200	NULL
,	NULL
designated	NULL
as	NULL
STAT6m	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Antiserum	NULL
to	NULL
hSTAT6	NULL
(	NULL
residues	NULL
787-804	NULL
,	NULL
designated	NULL
as	NULL
STATh2	NULL
)	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
William	NULL
J.	NULL
LaRochelle	NULL
(	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Abs	NULL
against	NULL
JAK1	NULL
and	NULL
JAK3	NULL
were	NULL
generated	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

mAb	NULL
against	NULL
phosphotyrosine	NULL
,	NULL
4G10	NULL
,	NULL
and	NULL
JAK	NULL
1	NULL
were	NULL
purchased	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

A	NULL
hybrid-oma	NULL
producing	NULL
Ab	NULL
against	NULL
CD3	NULL
(	NULL
OKT3	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
ATCC	NULL
)	NULL
(	NULL
Manassas	NULL
,	NULL
VA	NULL
)	NULL
.	NULL

Phytohemagglutinin	NULL
(	NULL
PHA	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Murex	NULL
Diagnostics	NULL
(	NULL
Darfort	NULL
,	NULL
England	NULL
)	NULL
.	NULL

Animal	NULL
care	NULL
was	NULL
provided	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
procedures	NULL
outlined	NULL
in	NULL
the	NULL
Guide	NULL
for	NULL
the	NULL
Care	NULL
and	NULL
Use	NULL
of	NULL
Laboratory	NULL
Animals	NULL
(	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Publication	NULL
No	NULL
.	NULL

86-23	NULL
,	NULL
1985	NULL
)	NULL
.	NULL

Purification	NULL
of	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
and	NULL
cell	NULL
stimulation	NULL
PBMC	NULL
were	NULL
separated	NULL
on	NULL
Ficoll-Hypaque	NULL
gradients	NULL
by	NULL
leukophoresis	NULL
packages	NULL
obtained	NULL
from	NULL
healthy	NULL
donors	NULL
through	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
blood	NULL
bank	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Leukocyte	NULL
suspensions	NULL
were	NULL
washed	NULL
in	NULL
HBSS	NULL
and	NULL
resuspended	NULL
in	NULL
RPMI	NULL
1640	NULL
containing	NULL
1	NULL
%	NULL
heat-inactivated	NULL
FCS	NULL
.	NULL

Adherent	NULL
cells	NULL
(	NULL
monocytes	NULL
and	NULL
B	NULL
cells	NULL
)	NULL
were	NULL
removed	NULL
by	NULL
adherence	NULL
to	NULL
plastic	NULL
dishes	NULL
to	NULL
nylon	NULL
wool	NULL
and	NULL
via	NULL
elutriation	NULL
.	NULL

Highly	NULL
enriched	NULL
populations	NULL
of	NULL
CD3*	NULL
CDS56~	NULL
T	NULL
cells	NULL
(	NULL
95-99	NULL
%	NULL
)	NULL
(	NULL
<	NULL
2	NULL
%	NULL
LGL	NULL
;	NULL
large	NULL
granular	NULL
lymphocytes	NULL
)	NULL
and	NULL
LGL	NULL
(	NULL
>	NULL
90	NULL
%	NULL
pure	NULL
)	NULL
(	NULL
<	NULL
10	NULL
%	NULL
CD3+*	NULL
T	NULL
cells	NULL
,	NULL
<	NULL
2	NULL
%	NULL
monocytes	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
PBMC	NULL
by	NULL
centrifugation	NULL
of	NULL
nylon	NULL
wool-passed	NULL
and	NULL
elutriated	NULL
cells	NULL
on	NULL
discontinuous	NULL
density	NULL
gradients	NULL
of	NULL
percoll	NULL
(	NULL
Pharmacia	NULL
Fine	NULL
Chemicals	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
.	NULL

The	NULL
purity	NULL
of	NULL
T	NULL
and	NULL
NK	NULL
cells	NULL
was	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Activation	NULL
was	NULL
monitored	NULL
by	NULL
surface	NULL
activation	NULL
Ag	NULL
expression	NULL
(	NULL
46	NULL
)	NULL
.	NULL

For	NULL
cytotoxicity	NULL
and	NULL
cytokine	NULL
secretion	NULL
assays	NULL
,	NULL
the	NULL
cell	NULL
cultures	NULL
were	NULL
treated	NULL
with	NULL
100	NULL
U/ml	NULL
of	NULL
IL-2	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
mAb	NULL
against	NULL
CD3/10®	NULL
T	NULL
cells	NULL
,	NULL
or	NULL
5	NULL
ug/ml	NULL
of	NULL
PHA	NULL
.	NULL

For	NULL
EMSA	NULL
,	NULL
freshly	NULL
isolated	NULL
human	NULL
NK	NULL
cells	NULL
and	NULL
T	NULL
cells	NULL
were	NULL
immediately	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
RPMI	NULL
1640	NULL
medium	NULL
to	NULL
remove	NULL
contaminating	NULL
percoll	NULL
.	NULL

Next	NULL
,	NULL
aliquoted	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
,	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
30	NULL
min	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
FCS	NULL
,	NULL
and	NULL
then	NULL
immediately	NULL
stimulated	NULL
with	NULL
various	NULL
cytokines	NULL
at	NULL
times	NULL
and	NULL
concentrations	NULL
described	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
.	NULL

Preactivated	NULL
T	NULL
cells	NULL
were	NULL
obtained	NULL
by	NULL
treating	NULL
freshly	NULL
isolated	NULL
T	NULL
cells	NULL
with	NULL
100	NULL
U/ml	NULL
IL-2	NULL
for	NULL
72	NULL
h.	NULL
For	NULL
EMSA	NULL
,	NULL
before	NULL
restimulation	NULL
,	NULL
cytokines	NULL
were	NULL
removed	NULL
from	NULL
the	NULL
cell	NULL
culture	NULL
by	NULL
washing	NULL
,	NULL
and	NULL
rested	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
1	NULL
%	NULL
FCS	NULL
for	NULL
24	NULL
h	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
2	NULL
X	NULL
10°	NULL
cells/ml	NULL
.	NULL

Cytotoxicity	NULL
assays	NULL
and	NULL
cytokine	NULL
measurement	NULL
Freshly	NULL
isolated	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
cytokines	NULL
.	NULL

The	NULL
cells	NULL
harvested	NULL
from	NULL
the	NULL
cultures	NULL
were	NULL
used	NULL
for	NULL
cytotoxic	NULL
assays	NULL
while	NULL
their	NULL
supernatants	NULL
were	NULL
collected	NULL
for	NULL
cytokine	NULL
analysis	NULL
.	NULL

In	NULL
the	NULL
cytotoxicity	NULL
assay	NULL
,	NULL
target	NULL
cells	NULL
,	NULL
K562	NULL
,	NULL
which	NULL
were	NULL
derived	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
in	NULL
blast	NULL
crisis	NULL
(	NULL
47	NULL
)	NULL
,	NULL
were	NULL
labeled	NULL
with	NULL
100	NULL
uCi	NULL
of	NULL
``	NULL
Cr	NULL
(	NULL
New	NULL
England	NULL
Nuclear	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
and	NULL
washed	NULL
.	NULL

Labeled	NULL
target	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
)	NULL
and	NULL
effector	NULL
cells	NULL
were	NULL
cultured	NULL
together	NULL
in	NULL
200	NULL
gl	NULL
of	NULL
medium	NULL
in	NULL
microtiter	NULL
plates	NULL
(	NULL
Linbro	NULL
,	NULL
Hamden	NULL
,	NULL
CT	NULL
)	NULL
at	NULL
several	NULL
effect-to-target	NULL
ratios	NULL
(	NULL
25:1	NULL
,	NULL
12:1	NULL
,	NULL
6:1	NULL
,	NULL
3:1	NULL
)	NULL
.	NULL

After	NULL
4	NULL
h	NULL
of	NULL
incubation	NULL
at	NULL
37°C	NULL
,	NULL
the	NULL
supernatant	NULL
was	NULL
harvested	NULL
and	NULL
counted	NULL
in	NULL
a	NULL
gamma	NULL
scintillation	NULL
counter	NULL
.	NULL

Cytotoxicity	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
amount	NULL
of	NULL
**Cr	NULL
released	NULL
219	NULL
from	NULL
lysed	NULL
target	NULL
cells	NULL
.	NULL

Three	NULL
replicates	NULL
were	NULL
used	NULL
per	NULL
experimental	NULL
group	NULL
,	NULL
and	NULL
the	NULL
percentage	NULL
of	NULL
specific	NULL
lysis	NULL
was	NULL
calculated	NULL
according	NULL
to	NULL
the	NULL
for-mula	NULL
:	NULL
lysis	NULL
=	NULL
100	NULL
X	NULL
[	NULL
(	NULL
cpm	NULL
in	NULL
experimental	NULL
wells	NULL
)	NULL
-	NULL
(	NULL
cpm	NULL
in	NULL
wells	NULL
with	NULL
target	NULL
cells	NULL
alone	NULL
)	NULL
]	NULL
/	NULL
(	NULL
{	NULL
cpm	NULL
incorporated	NULL
in	NULL
target	NULL
cells	NULL
)	NULL
.	NULL

IFN-y	NULL
production	NULL
was	NULL
measured	NULL
using	NULL
IFN-y	NULL
Elisa	NULL
Kits	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
.	NULL

All	NULL
samples	NULL
were	NULL
measured	NULL
in	NULL
duplicate	NULL
and	NULL
plotted	NULL
against	NULL
the	NULL
standard	NULL
curve	NULL
and	NULL
reported	NULL
as	NULL
pg/ml	NULL
.	NULL

In	NULL
all	NULL
assays	NULL
,	NULL
the	NULL
SD	NULL
of	NULL
cytokine	NULL
measurement	NULL
was	NULL
less	NULL
than	NULL
25	NULL
pg/ml	NULL
.	NULL

Proliferation	NULL
assay	NULL
Freshly	NULL
isolated	NULL
human	NULL
NK	NULL
or	NULL
T	NULL
cells	NULL
(	NULL
2	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
flat-bottom	NULL
96-well	NULL
plates	NULL
.	NULL

Each	NULL
sample	NULL
was	NULL
tested	NULL
in	NULL
triplicate	NULL
in	NULL
200:1	NULL
total	NULL
volume	NULL
.	NULL

After	NULL
2	NULL
to	NULL
3	NULL
days	NULL
culture	NULL
with	NULL
or	NULL
without	NULL
cytokines	NULL
,	NULL
wells	NULL
were	NULL
pulsed	NULL
with	NULL
1	NULL
Ci	NULL
of	NULL
methyl	NULL
[	NULL
°HJthymidine	NULL
(	NULL
[	NULL
°H	NULL
]	NULL
JTdR	NULL
;	NULL
DuPont	NULL
NEN	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
;	NULL
6.7	NULL
Ci/mmol	NULL
,	NULL
ICN	NULL
Radiochemicals	NULL
,	NULL
Costa	NULL
Mesa	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
harvested	NULL
4	NULL
h	NULL
later	NULL
on	NULL
a	NULL
Skatron	NULL
Cell	NULL
Harvester	NULL
(	NULL
Skatron	NULL
,	NULL
Sterling	NULL
,	NULL
VA	NULL
)	NULL
.	NULL

Thy-midine	NULL
incorporation	NULL
was	NULL
assessed	NULL
by	NULL
liquid	NULL
scintillation	NULL
counting	NULL
.	NULL

Flow	NULL
cytometry	NULL
analysis	NULL
Cells	NULL
were	NULL
stained	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Cell	NULL
sorting	NULL
was	NULL
performed	NULL
on	NULL
either	NULL
an	NULL
Epics	NULL
750	NULL
(	NULL
Coulter	NULL
Electronics	NULL
,	NULL
Hialeah	NULL
,	NULL
FL	NULL
)	NULL
or	NULL
a	NULL
FACStar	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
directly	NULL
stained	NULL
using	NULL
PE	NULL
or	NULL
FITC-labeled	NULL
primary	NULL
Abs	NULL
against	NULL
CD25	NULL
or	NULL
HLA-Dr	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
or	NULL
indirectly	NULL
stained	NULL
using	NULL
a	NULL
primary	NULL
Ab	NULL
followed	NULL
by	NULL
an	NULL
isotype-specific	NULL
FITC-labeled	NULL
or	NULL
PE-conjugated	NULL
secondary	NULL
or	NULL
biotinylated	NULL
primary	NULL
Ab	NULL
followed	NULL
by	NULL
Streptaviden	NULL
PE	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
or	NULL
Avidium	NULL
red	NULL
670	NULL
(	NULL
Becton	NULL
Dickinson	NULL
}	NULL
.	NULL

Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
once	NULL
with	NULL
cold	NULL
PBS	NULL
and	NULL
once	NULL
with	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
10	NULL
mM	NULL
KC	NULL
]	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
Na-vanadate	NULL
,	NULL
25	NULL
mM	NULL
NaF	NULL
,	NULL
10	NULL
mM	NULL
Na-pyrophosphate	NULL
,	NULL
and	NULL
25	NULL
mM	NULL
p-nitrophenyl	NULL
guanidinobenzoate	NULL
)	NULL
,	NULL
and	NULL
lysed	NULL
in	NULL
buffer	NULL
A	NULL
containing	NULL
0.05	NULL
%	NULL
NP4O	NULL
.	NULL

The	NULL
lysate	NULL
was	NULL
placed	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
and	NULL
centrifuged	NULL
at	NULL
4,000	NULL
rpm	NULL
and	NULL
4°C	NULL
for	NULL
4	NULL
min	NULL
to	NULL
remove	NULL
cyto-plasmic	NULL
proteins	NULL
.	NULL

The	NULL
nuclear	NULL
proteins	NULL
in	NULL
the	NULL
pellet	NULL
were	NULL
extracted	NULL
in	NULL
high	NULL
salt	NULL
buffer	NULL
(	NULL
410	NULL
mM	NULL
KCI	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
0.2	NULL
mM	NULL
EDTA	NULL
in	NULL
buffer	NULL
A	NULL
)	NULL
.	NULL

Insoluble	NULL
material	NULL
was	NULL
removed	NULL
by	NULL
centrifugation	NULL
at	NULL
15,000	NULL
rpm	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
measured	NULL
with	NULL
a	NULL
Bio-Rad	NULL
(	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
protein	NULL
assay	NULL
,	NULL
and	NULL
samples	NULL
were	NULL
stored	NULL
at	NULL
-70°C	NULL
until	NULL
use	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
EMSA	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
were	NULL
synthesized	NULL
in	NULL
DNA/RNA	NULL
Synthesizer	NULL
(	NULL
PE	NULL
Applied	NULL
Biosystems	NULL
,	NULL
Foster	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
double-stranded	NULL
oligonucleotides	NULL
containing	NULL
GAS-like	NULL
motifs	NULL
from	NULL
the	NULL
human	NULL
Ce	NULL
regulatory	NULL
region	NULL
(	NULL
5'-AGTCAAGACCTTTTCCCAA	NULL
GAAATCTATC-3	NULL
'	NULL
)	NULL
(	NULL
42	NULL
,	NULL
50	NULL
)	NULL
,	NULL
and	NULL
the	NULL
c-fos	NULL
promoter	NULL
sis-inducible	NULL
element	NULL
m67	NULL
SIE	NULL
(	NULL
5'-AGCTTGTCGACATTTCCCGTAAATCGTCGG-3	NULL
'	NULL
)	NULL
(	NULL
51	NULL
,	NULL
52	NULL
)	NULL
were	NULL
end-labeled	NULL
with	NULL
the	NULL
Klenow	NULL
fragment	NULL
DNA	NULL
polymerase	NULL
(	NULL
New	NULL
England	NULL
BioLabs	NULL
,	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
with	NULL
(	NULL
3000	NULL
Ci/mmol	NULL
;	NULL
Du-Pont	NULL
)	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Labeled	NULL
DNA	NULL
probe	NULL
was	NULL
further	NULL
purified	NULL
from	NULL
a	NULL
12	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
by	NULL
excising	NULL
the	NULL
corresponding	NULL
radioactive	NULL
band	NULL
after	NULL
electrophoresis	NULL
.	NULL

The	NULL
purified	NULL
DNA	NULL
probe	NULL
was	NULL
aliquoted	NULL
at	NULL
15,000	NULL
epm	NULL
per	NULL
pl	NULL
and	NULL
stored	NULL
at	NULL
-20°C	NULL
until	NULL
use	NULL
.	NULL

For	NULL
supershift	NULL
analysis	NULL
,	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
1	NULL
pl	NULL
antisera	NULL
to	NULL
STAT1a	NULL
,	NULL
STAT3	NULL
,	NULL
STAT5a	NULL
,	NULL
STAT5b	NULL
,	NULL
and	NULL
STAT6	NULL
,	NULL
while	NULL
1	NULL
pg	NULL
anti-STAT4	NULL
,	NULL
and	NULL
1-2	NULL
pl	NULL
normal	NULL
rabbit	NULL
serum	NULL
were	NULL
incubated	NULL
with	NULL
samples	NULL
for	NULL
2	NULL
h	NULL
on	NULL
ice	NULL
,	NULL
before	NULL
addition	NULL
of	NULL
*°P-labeled	NULL
DNA	NULL
probe	NULL
.	NULL

Cold	NULL
competition	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
unlabeled	NULL
wild-type	NULL
probes	NULL
or	NULL
Ce	NULL
GAS	NULL
motif-mutated	NULL
probes	NULL
(	NULL
GTC-CCAAGAC	NULL
)	NULL
.	NULL

Results	NULL
were	NULL
visualized	NULL
by	NULL
autoradiography	NULL
after	NULL
1	NULL
to	NULL
4	NULL
days	NULL
exposure	NULL
at	NULL
-70°C	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
Western	NULL
blotting	NULL
Immunoprecipitation	NULL
and	NULL
Western	NULL
blotting	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
classified	NULL
cell	NULL
lysates	NULL
were	NULL
incubated	NULL
with	NULL
anti-STAT6	NULL
antiserum	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

Abs	NULL
were	NULL
captured	NULL
by	NULL
incubation	NULL
for	NULL
30	NULL
min	NULL
with	NULL
protein	NULL
A-Sepharose	NULL
beads	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

Immunoprecipitated	NULL
protein	NULL
was	NULL
washed	NULL
and	NULL
eluted	NULL
by	NULL
boiling	NULL
in	NULL
SDS-sample	NULL
buffer	NULL
for	NULL
4	NULL
min	NULL
,	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
7.5	NULL
%	NULL
SDS-PAGE	NULL
under	NULL
reducing	NULL
conditions	NULL
.	NULL

Proteins	NULL
were	NULL
transferred	NULL
to	NULL
the	NULL
polyvinylidene	NULL
difluoride	NULL
(	NULL
PVDF	NULL
)	NULL
membrane	NULL
(	NULL
Immo-bilon	NULL
;	NULL
Millipore	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
;	NULL
Cat	NULL
No	NULL
.	NULL

1PVH	NULL
00010	NULL
)	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
blotted	NULL
with	NULL
4G10	NULL
and	NULL
then	NULL
stripped	NULL
and	NULL
reblotted	NULL
with	NULL
anti-STAT6	NULL
antiserum	NULL
.	NULL

Proteins	NULL
were	NULL
detected	NULL
with	NULL
an	NULL
ECL	NULL
kit	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
,	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
220	NULL
Table	NULL
I	NULL
.	NULL

-	NULL
Effect	NULL
of	NULL
IL-4	NULL
and	NULL
IL-13	NULL
on	NULL
IFN-y	NULL
production	NULL
and	NULL
LAK	NULL
activity	NULL
in	NULL
primary	NULL
NK	NULL
cells	NULL
``	NULL
EFFECTS	NULL
OF	NULL
IL-13	NULL
ON	NULL
NK	NULL
AND	NULL
T	NULL
CELLS	NULL
Table	NULL
II	NULL
.	NULL

-	NULL
Effect	NULL
of	NULL
IL-4	NULL
and	NULL
IL-13	NULL
on	NULL
lytic	NULL
activity	NULL
,	NULL
IFN-y	NULL
production	NULL
,	NULL
CD25	NULL
,	NULL
and	NULL
HLA-Dr	NULL
expression	NULL
in	NULL
primary	NULL
T	NULL
cells	NULL
``	NULL
IFN-y	NULL
(	NULL
pg/ml	NULL
)	NULL
LAK	NULL
Activity	NULL
Cytokines	NULL
(	NULL
per	NULL
ml	NULL
)	NULL
Donor	NULL
1	NULL
Donor	NULL
2	NULL
Donor	NULL
1	NULL
Donor	NULL
2	NULL
Medium	NULL
4	NULL
0	NULL
24	NULL
10	NULL
IL-2	NULL
(	NULL
50	NULL
U	NULL
)	NULL
24	NULL
123	NULL
4584	NULL
545	NULL
IL-4	NULL
(	NULL
10	NULL
ng	NULL
)	NULL
5	NULL
0	NULL
20	NULL
1	NULL
IL-4	NULL
(	NULL
100	NULL
ng	NULL
)	NULL
1	NULL
0	NULL
51	NULL
1	NULL
IL-4	NULL
(	NULL
1000	NULL
ng	NULL
)	NULL
12	NULL
0	NULL
32	NULL
2	NULL
IL-13	NULL
(	NULL
10	NULL
ng	NULL
)	NULL
3	NULL
3	NULL
30	NULL
23	NULL
IL-13	NULL
(	NULL
100	NULL
ng	NULL
)	NULL
28	NULL
8	NULL
213	NULL
30	NULL
IL-13	NULL
(	NULL
1000	NULL
ng	NULL
)	NULL
57	NULL
7	NULL
220	NULL
24	NULL
IL-2	NULL
+	NULL
IL-4	NULL
(	NULL
10	NULL
)	NULL
2	NULL
1	NULL
121	NULL
41	NULL
IL-2	NULL
+	NULL
IL-4	NULL
(	NULL
100	NULL
)	NULL
4	NULL
0	NULL
273	NULL
52	NULL
IL-2	NULL
+	NULL
IL-4	NULL
(	NULL
1000	NULL
)	NULL
3	NULL
0	NULL
142	NULL
42	NULL
IL-2	NULL
+	NULL
IL-13	NULL
(	NULL
10	NULL
)	NULL
293	NULL
80	NULL
2188	NULL
253	NULL
IL-2	NULL
+	NULL
IL-13	NULL
(	NULL
100	NULL
)	NULL
690	NULL
50	NULL
3410	NULL
312	NULL
IL-2	NULL
+	NULL
IL-13	NULL
(	NULL
1000	NULL
)	NULL
695	NULL
60	NULL
3488	NULL
356	NULL
``	NULL
Primary	NULL
NK	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
medium	NULL
,	NULL
50	NULL
U/ml	NULL
of	NULL
IL-2	NULL
,	NULL
or	NULL
10	NULL
,	NULL
100	NULL
,	NULL
or	NULL
1000	NULL
ng/ml	NULL
of	NULL
IL-13	NULL
,	NULL
or	NULL
10	NULL
,	NULL
100	NULL
,	NULL
or	NULL
1000	NULL
ng/ml	NULL
of	NULL
IL-4	NULL
,	NULL
or	NULL
combinations	NULL
of	NULL
IL-2	NULL
with	NULL
different	NULL
doses	NULL
of	NULL
IL-13	NULL
or	NULL
IL-4	NULL
for	NULL
18	NULL
h.	NULL
The	NULL
cells	NULL
then	NULL
were	NULL
harvested	NULL
for	NULL
cytotoxicity	NULL
assay	NULL
(	NULL
denoted	NULL
as	NULL
LAK	NULL
potential	NULL
)	NULL
,	NULL
and	NULL
the	NULL
supernatants	NULL
were	NULL
analyzed	NULL
for	NULL
IFN-y	NULL
levels	NULL
(	NULL
indicated	NULL
as	NULL
pg/ml	NULL
)	NULL
.	NULL

From	NULL
nine	NULL
donors	NULL
,	NULL
Donor	NULL
1	NULL
and	NULL
Donor	NULL
2	NULL
were	NULL
selected	NULL
as	NULL
representatives	NULL
for	NULL
two	NULL
distinct	NULL
NK	NULL
cell	NULL
responses	NULL
from	NULL
five	NULL
and	NULL
four	NULL
donors	NULL
,	NULL
respectively	NULL
.	NULL

Lytic	NULL
potential	NULL
was	NULL
calculated	NULL
at	NULL
E	NULL
:	NULL
T	NULL
ratio	NULL
of	NULL
25:1	NULL
.	NULL

Results	NULL
IL-13	NULL
regulates	NULL
IFN-y	NULL
production	NULL
in	NULL
primary	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
To	NULL
examine	NULL
whether	NULL
IL-13	NULL
and	NULL
IL-4	NULL
differentially	NULL
regulate	NULL
IFN-y	NULL
production	NULL
in	NULL
primary	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
,	NULL
fresh	NULL
primary	NULL
NK	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
medium	NULL
,	NULL
10	NULL
,	NULL
100	NULL
,	NULL
and	NULL
1,000	NULL
ng/ml	NULL
of	NULL
IL-13	NULL
,	NULL
or	NULL
10	NULL
,	NULL
100	NULL
,	NULL
and	NULL
1,000	NULL
ng/ml	NULL
of	NULL
IL-4	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
50	NULL
U/ml	NULL
of	NULL
IL-2	NULL
for	NULL
18	NULL
h.	NULL
Fresh	NULL
primary	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
100	NULL
ng/ml	NULL
of	NULL
IL-4	NULL
or	NULL
100	NULL
ng/ml	NULL
of	NULL
IL-13	NULL
in	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
anti-CD3	NULL
mAb	NULL
(	NULL
1	NULL
mg/10°	NULL
cells	NULL
)	NULL
/IL-2	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
or	NULL
PHA	NULL
(	NULL
5	NULL
pg/ml	NULL
)	NULL
for	NULL
48	NULL
h.	NULL
Supernatants	NULL
from	NULL
these	NULL
cultures	NULL
were	NULL
harvested	NULL
for	NULL
the	NULL
measurement	NULL
of	NULL
IFN-y	NULL
by	NULL
ELISA	NULL
whereas	NULL
the	NULL
cells	NULL
were	NULL
collected	NULL
for	NULL
cytotoxicity	NULL
assays	NULL
(	NULL
discussed	NULL
below	NULL
)	NULL
.	NULL

In	NULL
primary	NULL
NK	NULL
cells	NULL
,	NULL
IL-13	NULL
,	NULL
but	NULL
not	NULL
IL-4	NULL
,	NULL
could	NULL
induce	NULL
low	NULL
levels	NULL
of	NULL
IFN-y	NULL
secretion	NULL
in	NULL
both	NULL
representative	NULL
donors	NULL
(	NULL
Table	NULL
I	NULL
,	NULL
donors	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

When	NULL
NK	NULL
cells	NULL
were	NULL
costimulated	NULL
with	NULL
IL-13	NULL
and	NULL
IL-2	NULL
,	NULL
IL-13	NULL
generally	NULL
resulted	NULL
in	NULL
two	NULL
types	NULL
of	NULL
reactivity	NULL
from	NULL
nine	NULL
donors	NULL
tested	NULL
.	NULL

Donor	NULL
1	NULL
is	NULL
representatives	NULL
of	NULL
five	NULL
of	NULL
nine	NULL
donors	NULL
,	NULL
in	NULL
which	NULL
IL-13	NULL
synergized	NULL
with	NULL
IL-2	NULL
to	NULL
stimulate	NULL
IFN-y	NULL
production	NULL
(	NULL
3-	NULL
to	NULL
27-fold	NULL
increase	NULL
)	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
and	NULL
is	NULL
consistent	NULL
with	NULL
previous	NULL
reports	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
donor	NULL
2	NULL
represents	NULL
four	NULL
of	NULL
nine	NULL
donors	NULL
where	NULL
IL-13	NULL
modestly	NULL
inhibited	NULL
IFN-y	NULL
production	NULL
(	NULL
about	NULL
a	NULL
twofold	NULL
reduction	NULL
)	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Currently	NULL
,	NULL
the	NULL
reasons	NULL
for	NULL
variability	NULL
in	NULL
IFN-y	NULL
production	NULL
,	NULL
probably	NULL
resulting	NULL
from	NULL
the	NULL
differences	NULL
between	NULL
NK	NULL
cell	NULL
populations	NULL
in	NULL
response	NULL
to	NULL
IL-13	NULL
stimulation	NULL
,	NULL
are	NULL
unknown	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
IL-13R	NULL
or	NULL
IL-2R	NULL
expression	NULL
,	NULL
signaling	NULL
molecules	NULL
,	NULL
and	NULL
differentiation	NULL
states	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
in	NULL
both	NULL
types	NULL
of	NULL
donors	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
IL-13	NULL
on	NULL
IFN-y	NULL
production	NULL
was	NULL
in	NULL
marked	NULL
contrast	NULL
to	NULL
the	NULL
strong	NULL
inhibition	NULL
seen	NULL
with	NULL
IL-4	NULL
in	NULL
NK	NULL
cells	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
since	NULL
10	NULL
ng/ml	NULL
of	NULL
IL-4	NULL
was	NULL
able	NULL
to	NULL
effectively	NULL
inhibit	NULL
IL-2-induced	NULL
IFN-y	NULL
production	NULL
.	NULL

In	NULL
primary	NULL
T	NULL
cells	NULL
,	NULL
IL-4	NULL
or	NULL
IL-13	NULL
alone	NULL
did	NULL
not	NULL
induce	NULL
a	NULL
detectable	NULL
level	NULL
of	NULL
IFN-y	NULL
production	NULL
(	NULL
Table	NULL
II	NULL
)	NULL
.	NULL

However	NULL
,	NULL
different	NULL
levels	NULL
of	NULL
IFN-y	NULL
production	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
cultures	NULL
in	NULL
which	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
anti-CD3	NULL
mAb/IL-2	NULL
or	NULL
PHA	NULL
(	NULL
Table	NULL
II	NULL
)	NULL
.	NULL

IL-13	NULL
inhibited	NULL
both	NULL
anti-CD3	NULL
mAb/IL-2-	NULL
and	NULL
PHA-mediated	NULL
IFN-y	NULL
production	NULL
(	NULL
approximately	NULL
50	NULL
%	NULL
reduction	NULL
)	NULL
while	NULL
IL-4	NULL
inhibited	NULL
only	NULL
PHA-induced	NULL
IFN-y	NULL
production	NULL
.	NULL

This	NULL
inhibition	NULL
was	NULL
not	NULL
seen	NULL
in	NULL
anti-CD3/IL-2-treated	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
IFN-y	NULL
Lytic	NULL
CD24	NULL
Dr	NULL
Stimulation	NULL
(	NULL
pg/ml	NULL
)	NULL
Activity	NULL
(	NULL
%	NULL
)	NULL
(	NULL
%	NULL
)	NULL
Medium	NULL
0	NULL
7	NULL
6	NULL
2	NULL
IL-4	NULL
0	NULL
1	NULL
9	NULL
1	NULL
IL-13	NULL
0	NULL
1	NULL
4	NULL
2	NULL
CD3AIL-2	NULL
127	NULL
331	NULL
35	NULL
14	NULL
CD3AIL-2	NULL
+	NULL
IL-4	NULL
174	NULL
6599	NULL
38	NULL
18	NULL
CD3AIL-2	NULL
+	NULL
IL-13	NULL
62	NULL
1053	NULL
50	NULL
24	NULL
PHA	NULL
632	NULL
NT	NULL
``	NULL
81	NULL
40	NULL
PHA	NULL
+	NULL
IL-4	NULL
342	NULL
.	NULL

NT	NULL
90	NULL
26	NULL
PHA	NULL
+	NULL
IL-13	NULL
281	NULL
NT	NULL
94	NULL
36	NULL
``	NULL
Primary	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
medium	NULL
,	NULL
mAb	NULL
against	NULL
CD3	NULL
plus	NULL
IL-2	NULL
,	NULL
or	NULL
PHA	NULL
alone	NULL
,	NULL
or	NULL
in	NULL
combination	NULL
of	NULL
100	NULL
ng/ml	NULL
of	NULL
IL-13	NULL
or	NULL
100	NULL
ng/ml	NULL
IL-4	NULL
,	NULL
respectively	NULL
,	NULL
with	NULL
mAb	NULL
against	NULL
CD3/IL-2	NULL
or	NULL
PHA	NULL
for	NULL
48	NULL
h.	NULL
The	NULL
cytokince-treated	NULL
cells	NULL
were	NULL
used	NULL
in	NULL
a	NULL
cytotoxicity	NULL
assay	NULL
against	NULL
K562	NULL
(	NULL
denoted	NULL
as	NULL
LAK	NULL
potential	NULL
)	NULL
,	NULL
or	NULL
measurements	NULL
of	NULL
CD25	NULL
or	NULL
Class	NULL
II	NULL
(	NULL
HLA-Dr	NULL
)	NULL
expression	NULL
(	NULL
indicated	NULL
%	NULL
of	NULL
cells	NULL
)	NULL
,	NULL
and	NULL
IFN-y	NULL
secretion	NULL
(	NULL
denoted	NULL
as	NULL
pg/m	NULL
!	NULL
)	NULL

.	NULL

inhibition	NULL
might	NULL
vary	NULL
under	NULL
certain	NULL
T	NULL
cell	NULL
activation	NULL
conditions	NULL
.	NULL

However	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
might	NULL
express	NULL
a	NULL
functional	NULL
IL-13R	NULL
,	NULL
and	NULL
IL-13	NULL
and	NULL
IL-4	NULL
may	NULL
have	NULL
different	NULL
roles	NULL
in	NULL
regulating	NULL
IFN-y	NULL
production	NULL
in	NULL
these	NULL
cell	NULL
types	NULL
.	NULL

IL-13	NULL
regulates	NULL
cytolytic	NULL
activity	NULL
in	NULL
primary	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
The	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
from	NULL
the	NULL
above-mentioned	NULL
cultures	NULL
were	NULL
utilized	NULL
for	NULL
cytotoxicity	NULL
assays	NULL
.	NULL

IL-13	NULL
itself	NULL
induced	NULL
low	NULL
NK	NULL
cytolytic	NULL
activity	NULL
,	NULL
while	NULL
IL-4	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
Table	NULL
I	NULL
,	NULL
donors	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
IL-13	NULL
had	NULL
a	NULL
lower	NULL
(	NULL
less	NULL
than	NULL
50	NULL
%	NULL
)	NULL
inhibitory	NULL
effect	NULL
on	NULL
the	NULL
IL-2-induced	NULL
NK	NULL
cytolytic	NULL
activity	NULL
(	NULL
Table	NULL
I	NULL
,	NULL
donors	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
which	NULL
was	NULL
different	NULL
from	NULL
the	NULL
previous	NULL
report	NULL
that	NULL
demonstrated	NULL
that	NULL
IL-13	NULL
could	NULL
increase	NULL
the	NULL
IL-2-induced	NULL
LAK	NULL
activity	NULL
(	NULL
4	NULL
)	NULL
.	NULL

This	NULL
difference	NULL
is	NULL
probably	NULL
due	NULL
to	NULL
donor-to-donor	NULL
variations	NULL
or	NULL
possibly	NULL
different	NULL
sources	NULL
of	NULL
IL-13	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
as	NULL
previously	NULL
reported	NULL
(	NULL
53	NULL
)	NULL
,	NULL
IL-4	NULL
strongly	NULL
suppressed	NULL
IL-2-mediated	NULL
LAK	NULL
potential	NULL
(	NULL
>	NULL
90	NULL
%	NULL
re-duction	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
both	NULL
IL-13	NULL
and	NULL
IL-4	NULL
have	NULL
an	NULL
inhibitory	NULL
effect	NULL
on	NULL
IL-2-induced	NULL
NK	NULL
cytolytic	NULL
activity	NULL
,	NULL
but	NULL
IL-4	NULL
is	NULL
a	NULL
more	NULL
potent	NULL
inhibitor	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
previous	NULL
reports	NULL
that	NULL
IL-13	NULL
and	NULL
IL-4	NULL
have	NULL
different	NULL
roles	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
LAK	NULL
activity	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
,	NULL
IL-13	NULL
or	NULL
IL-4	NULL
alone	NULL
did	NULL
not	NULL
induce	NULL
T	NULL
cell	NULL
cytolytic	NULL
activity	NULL
(	NULL
Table	NULL
II	NULL
)	NULL
.	NULL

If	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
mAb/	NULL
IL-2	NULL
for	NULL
48	NULL
h	NULL
,	NULL
a	NULL
low	NULL
level	NULL
of	NULL
T	NULL
cell	NULL
cytolytic	NULL
activity	NULL
was	NULL
detected	NULL
.	NULL

However	NULL
,	NULL
when	NULL
T	NULL
cells	NULL
were	NULL
costimulated	NULL
with	NULL
anti-CD3	NULL
mAb/	NULL
IL-2	NULL
and	NULL
either	NULL
IL-13	NULL
or	NULL
IL-4	NULL
,	NULL
both	NULL
IL-4	NULL
and	NULL
IL-13	NULL
increased	NULL
the	NULL
cytolytic	NULL
potential	NULL
of	NULL
T	NULL
cells	NULL
although	NULL
IL-4	NULL
is	NULL
much	NULL
more	NULL
potent	NULL
(	NULL
Table	NULL
II	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
previous	NULL
report	NULL
that	NULL
IL-4	NULL
augmented	NULL
LAK	NULL
activity	NULL
with	NULL
other	NULL
T	NULL
cell	NULL
mitogens	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
IL-2	NULL
(	NULL
54	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
NK	NULL
cells	NULL
,	NULL
IL-4	NULL
and	NULL
IL-13	NULL
inhibited	NULL
IL-2-mediated	NULL
LAK	NULL
activity	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
are	NULL
responsive	NULL
to	NULL
IL-13	NULL
stimulation	NULL
and	NULL
that	NULL
IL-13	NULL
,	NULL
like	NULL
IL-4	NULL
,	NULL
can	NULL
differentially	NULL
regulate	NULL
cytolytic	NULL
activity	NULL
in	NULL
T	NULL
and	NULL
NK	NULL
cells	NULL
.	NULL

IL-13	NULL
inhibits	NULL
IL-2-induced	NULL
NK	NULL
cell	NULL
proliferation	NULL
,	NULL
but	NULL
has	NULL
no	NULL
significant	NULL
proliferative	NULL
activity	NULL
in	NULL
primary	NULL
T	NULL
and	NULL
NK	NULL
cells	NULL
Previous	NULL
reports	NULL
have	NULL
demonstrated	NULL
that	NULL
IL-4	NULL
can	NULL
inhibit	NULL
IL-2-dependent	NULL
proliferation	NULL
of	NULL
human	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
(	NULL
53	NULL
,	NULL
55	NULL
)	NULL
,	NULL
but	NULL
the	NULL
effect	NULL
of	NULL
IL-13	NULL
on	NULL
NK	NULL
cell	NULL
proliferation	NULL
has	NULL
not	NULL
been	NULL
determined	NULL
.	NULL

Freshly	NULL
isolated	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
60	NULL
h	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
10	NULL
and	NULL
100	NULL
U/ml	NULL
of	NULL
IL-2	NULL
,	NULL
10	NULL
and	NULL
100	NULL
ng/ml	NULL
of	NULL
IL-13	NULL
,	NULL
or	NULL
10	NULL
and	NULL
100/ml	NULL
of	NULL
IL-4	NULL
alone	NULL
or	NULL
in	NULL
combinations	NULL
of	NULL
IL-2	NULL
with	NULL
IL-13	NULL
or	NULL
IL-4	NULL
as	NULL
indicated	NULL
in	NULL
Figure	NULL
1	NULL
.	NULL

In	NULL
NK	NULL
cells	NULL
,	NULL
the	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Medium	NULL
IL-2	NULL
10U	NULL
IL-2	NULL
100U	NULL
IL-13	NULL
10ng	NULL
IL-13	NULL
100ng	NULL
IL-4	NULL
10ng	NULL
IL-4	NULL
100ng	NULL
2	NULL
(	NULL
10	NULL
)	NULL
/13	NULL
(	NULL
10	NULL
)	NULL
2	NULL
(	NULL
100	NULL
)	NULL
/13	NULL
(	NULL
100	NULL
2	NULL
(	NULL
10	NULL
)	NULL
/4	NULL
(	NULL
10	NULL
)	NULL
2	NULL
(	NULL
100	NULL
)	NULL
/4	NULL
(	NULL
100	NULL
)	NULL
0	NULL
5	NULL
10	NULL
15	NULL
20	NULL
25	NULL
(	NULL
Thousands	NULL
)	NULL
CPM	NULL
Incorporation	NULL
3H-Thymidine	NULL
Medium	NULL
B	NULL
IL-2	NULL
10U	NULL
IL-2	NULL
100U	NULL
IL-13	NULL
10ng	NULL
IL-13	NULL
100ng	NULL
IL-4	NULL
10ng	NULL
IL-4	NULL
100ng	NULL
2	NULL
(	NULL
10	NULL
)	NULL
/13	NULL
(	NULL
10	NULL
)	NULL
2	NULL
(	NULL
100	NULL
)	NULL
/13	NULL
(	NULL
100	NULL
2	NULL
(	NULL
10	NULL
)	NULL
/4	NULL
(	NULL
10	NULL
)	NULL
2	NULL
(	NULL
100	NULL
)	NULL
/4	NULL
(	NULL
100	NULL
)	NULL
0	NULL
400	NULL
800	NULL
2000	NULL
1200	NULL
CPM	NULL
Incorporation	NULL
3H-Thymidine	NULL
1600	NULL
FIGURE	NULL
1	NULL
.	NULL

IL-13	NULL
and	NULL
IL-4	NULL
exhibit	NULL
a	NULL
similar	NULL
inhibitory	NULL
effect	NULL
on	NULL
IL-2-mediated	NULL
proliferation	NULL
of	NULL
NK	NULL
cells	NULL
.	NULL

[	NULL
°H	NULL
]	NULL
thymidine	NULL
incorporation	NULL
assays	NULL
were	NULL
performed	NULL
in	NULL
2	NULL
X	NULL
10°	NULL
primary	NULL
NK	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
and	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
in	NULL
200:1	NULL
medium	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
medium	NULL
,	NULL
10	NULL
and	NULL
100	NULL
U/ml	NULL
IL-2	NULL
,	NULL
10	NULL
and	NULL
100	NULL
ng/ml	NULL
IL-13	NULL
,	NULL
10	NULL
and	NULL
100	NULL
ng/ml	NULL
IL-4	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
the	NULL
combination	NULL
of	NULL
IL-2	NULL
with	NULL
either	NULL
IL-13	NULL
or	NULL
IL-4	NULL
as	NULL
indicated	NULL
.	NULL

Results	NULL
are	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
triplets	NULL
.	NULL

The	NULL
data	NULL
was	NULL
repeated	NULL
in	NULL
three	NULL
experiments	NULL
in	NULL
NK	NULL
cells	NULL
and	NULL
in	NULL
two	NULL
experiments	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

results	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
thymidine	NULL
incorporation	NULL
experiments	NULL
showed	NULL
that	NULL
10	NULL
or	NULL
100	NULL
U/ml	NULL
of	NULL
IL-2	NULL
significantly	NULL
induced	NULL
NK	NULL
cell	NULL
proliferation	NULL
while	NULL
10	NULL
or	NULL
100	NULL
ng/ml	NULL
of	NULL
IL-13	NULL
or	NULL
IL-4	NULL
did	NULL
not	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
IL-13	NULL
,	NULL
like	NULL
IL-4	NULL
,	NULL
might	NULL
not	NULL
be	NULL
a	NULL
NK	NULL
cell	NULL
mitogen	NULL
.	NULL

However	NULL
,	NULL
when	NULL
IL-13	NULL
was	NULL
combined	NULL
with	NULL
IL-2	NULL
,	NULL
IL-13	NULL
inhibited	NULL
IL-2-induced	NULL
NK	NULL
cell	NULL
proliferation	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
,	NULL
similar	NULL
to	NULL
that	NULL
ob	NULL
NK	NULL
Cell	NULL
:	NULL
FIGURE	NULL
2	NULL
.	NULL

IL-13	NULL
displays	NULL
distinct	NULL
Ce	NULL
DNA-pro-	NULL
g	NULL
tein-binding	NULL
complexes	NULL
in	NULL
primary	NULL
human	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
Primary	NULL
NK	NULL
(	NULL
Zanes	NULL
1-5	NULL
)	NULL
and	NULL
T	NULL
cells	NULL
(	NULL
lanes	NULL
6-10	NULL
)	NULL
were	NULL
stimulated	NULL
by	NULL
medium	NULL
as	NULL
control	NULL
(	NULL
CTRL	NULL
)	NULL
,	NULL
IL-6	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
,	NULL
IL-4	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
,	NULL
IL-13	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
,	NULL
or	NULL
IL-12	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Ten	NULL
micrograms	NULL
of	NULL
nuclear	NULL
proteins	NULL
prepared	NULL
from	NULL
each	NULL
sample	NULL
were	NULL
used	NULL
for	NULL
EMSA	NULL
using	NULL
*P-labeled	NULL
Ce	NULL
GAS	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

B	NULL
,	NULL
The	NULL
same	NULL
nuclear	NULL
extracts	NULL
described	NULL
in	NULL
(	NULL
A	NULL
)	NULL
were	NULL
used	NULL
for	NULL
EMSA	NULL
using	NULL
a	NULL
SIE	NULL
GAS	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

Arrows	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
denote	NULL
DNA-protein	NULL
complexes	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C.	NULL
Bracket	NULL
indicates	NULL
free	NULL
*°P-labeled	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

Similar	NULL
data	NULL
was	NULL
obtained	NULL
from	NULL
cells	NULL
obtained	NULL
from	NULL
four	NULL
other	NULL
donors	NULL
.	NULL

L	NULL
IL-12	NULL
|	NULL
221	NULL
served	NULL
with	NULL
IL-4	NULL
(	NULL
53	NULL
)	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
IL-13	NULL
on	NULL
NK	NULL
cell	NULL
proliferation	NULL
is	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
IL-4	NULL
.	NULL

In	NULL
primary	NULL
T	NULL
cells	NULL
,	NULL
although	NULL
IL-2	NULL
alone	NULL
weakly	NULL
induced	NULL
T	NULL
cell	NULL
proliferation	NULL
,	NULL
IL-13	NULL
did	NULL
not	NULL
have	NULL
a	NULL
significant	NULL
effect	NULL
on	NULL
T	NULL
cell	NULL
proliferation	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IL-4	NULL
itself	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
IL-2	NULL
,	NULL
had	NULL
a	NULL
stimulatory	NULL
(	NULL
or	NULL
additive	NULL
)	NULL
effect	NULL
on	NULL
primary	NULL
T	NULL
cell	NULL
proliferation	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
previous	NULL
report	NULL
that	NULL
IL-4	NULL
stimulates	NULL
T	NULL
cell	NULL
growth	NULL
by	NULL
an	NULL
IL-2-independent	NULL
mechanism	NULL
(	NULL
56	NULL
)	NULL
.	NULL

The	NULL
inhibitory	NULL
effects	NULL
of	NULL
IL-4	NULL
on	NULL
IL-2-dependent	NULL
proliferation	NULL
of	NULL
T	NULL
cells	NULL
occurred	NULL
when	NULL
T	NULL
cells	NULL
also	NULL
were	NULL
costimulated	NULL
with	NULL
anti-CD3	NULL
Ab	NULL
(	NULL
57	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
IL-13	NULL
or	NULL
IL-4	NULL
alone	NULL
did	NULL
not	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
CD25	NULL
and	NULL
HLA-Dr	NULL
molecules	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
,	NULL
while	NULL
the	NULL
stimulation	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
anti-CD3	NULL
mAb/IL-2	NULL
or	NULL
PHA	NULL
significantly	NULL
induced	NULL
CD25	NULL
and	NULL
HLA-Dr	NULL
expression	NULL
(	NULL
Table	NULL
II	NULL
)	NULL
.	NULL

IL-13	NULL
,	NULL
but	NULL
not	NULL
IL-4	NULL
,	NULL
when	NULL
used	NULL
in	NULL
combination	NULL
with	NULL
anti-CD3	NULL
mAb/IL-2	NULL
,	NULL
increased	NULL
the	NULL
number	NULL
of	NULL
T	NULL
cells	NULL
expressing	NULL
CD25	NULL
(	NULL
from	NULL
35	NULL
%	NULL
to	NULL
50	NULL
%	NULL
)	NULL
and	NULL
HLA-Dr	NULL
(	NULL
from	NULL
14	NULL
%	NULL
to	NULL
24	NULL
%	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
PHA	NULL
is	NULL
more	NULL
effective	NULL
than	NULL
anti-CD3-Ab/IL-2	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
CD25	NULL
and	NULL
HLA-Dr	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
PHA-stimulated	NULL
T	NULL
cells	NULL
potentially	NULL
express	NULL
more	NULL
high	NULL
affinity	NULL
IL-2R	NULL
than	NULL
anti-CD3	NULL
Ab/IL-2	NULL
stimulated	NULL
ones	NULL
,	NULL
suggesting	NULL
that	NULL
IL-13	NULL
might	NULL
expand	NULL
the	NULL
pool	NULL
of	NULL
IL-2	NULL
responding	NULL
cells	NULL
(	NULL
Table	NULL
II	NULL
)	NULL
.	NULL

IL-13	NULL
,	NULL
like	NULL
IL-4	NULL
,	NULL
induces	NULL
distinct	NULL
Ce	NULL
DNA-protein	NULL
binding	NULL
complexes	NULL
in	NULL
fresh	NULL
primary	NULL
human	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
Transcription	NULL
factor	NULL
STAT6	NULL
is	NULL
one	NULL
of	NULL
the	NULL
key	NULL
elements	NULL
in	NULL
the	NULL
transduction	NULL
of	NULL
IL-4-mediated	NULL
signaling	NULL
(	NULL
41-43	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
were	NULL
responsive	NULL
to	NULL
IL-13	NULL
stimulation	NULL
resulting	NULL
in	NULL
STAT6	NULL
activation	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
fresh	NULL
primary	NULL
T	NULL
and	NULL
NK	NULL
cells	NULL
stimulated	NULL
with	NULL
IL-13	NULL
,	NULL
IL-4	NULL
(	NULL
positive	NULL
control	NULL
)	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
IL-12	NULL
(	NULL
negative	NULL
control	NULL
)	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Using	NULL
a	NULL
Ce	NULL
STAT6	NULL
DNA-binding	NULL
element	NULL
as	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
42	NULL
,	NULL
50	NULL
)	NULL
,	NULL
EMSA	NULL
analysis	NULL
revealed	NULL
that	NULL
IL-13	NULL
and	NULL
IL-4	NULL
induced	NULL
two	NULL
similar	NULL
Ce	NULL
DNA-protein	NULL
complexes	NULL
in	NULL
fresh	NULL
primary	NULL
NK	NULL
cells	NULL
,	NULL
which	NULL
were	NULL
designated	NULL
as	NULL
complexes	NULL
B	NULL
and	NULL
C	NULL
,	NULL
according	NULL
to	NULL
their	NULL
electrophoretic	NULL
mobility	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

We	NULL
also	NULL
observed	NULL
a	NULL
slow	NULL
migrating	NULL
band	NULL
(	NULL
designated	NULL
as	NULL
complex	NULL
A	NULL
)	NULL
induced	NULL
by	NULL
IL-13	NULL
and	NULL
IL-4	NULL
in	NULL
fresh	NULL
primary	NULL
T	NULL
cells	NULL
(	NULL
Zanes	NULL
8	NULL
and	NULL
9	NULL
)	NULL
that	NULL
was	NULL
not	NULL
seen	NULL
in	NULL
NK	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
complex	NULL
C	NULL
appeared	NULL
constitutively	NULL
at	NULL
low	NULL
levels	NULL
in	NULL
primary	NULL
T	NULL
cells	NULL
in	NULL
some	NULL
donors	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IL-6	NULL
and	NULL
IL-12	NULL
did	NULL
not	NULL
induce	NULL
any	NULL
specific	NULL
DNA	NULL
protein	NULL
complex	NULL
with	NULL
this	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
7	NULL
,	NULL
and	NULL
10	NULL
)	NULL
.	NULL

These	NULL
results	NULL
revealed	NULL
several	NULL
interesting	NULL
findings	NULL
.	NULL

First	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
IL-13	NULL
to	NULL
induce	NULL
Ce	NULL
GAS	NULL
DNA-protein	NULL
NK	NULL
Cells	NULL
T	NULL
1	NULL
#	NULL
o=	NULL
16	NULL
+	NULL
bos	NULL
u	NULL
bd	NULL
*~C	NULL
HHHH	NULL
“	NULL
busy	NULL
lath	NULL
Muah	NULL
toot	NULL
Hout	NULL
©	NULL
ms	NULL
**	NULL
MMH	NULL
bn	NULL
ta	NULL
tabla	NULL
Luka	NULL
13z	NULL
.	NULL

7	NULL
8	NULL
9	NULL
10	NULL
T	NULL
Cells	NULL
7	NULL
T	NULL
-	NULL
=	NULL
CTRL	NULL
_6	NULL
-4	NULL
IL-13	NULL
IL-12	NULL
CTRL	NULL
IL-13	NULL
IL-12	NULL
CTRL	NULL
IL-13	NULL
IL-12	NULL
(	NULL
filth	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
222	NULL
Primary	NULL
T	NULL
Cells	NULL
IL-13	NULL
7T	NULL
IL-13	NULL
|	NULL
1	NULL
=	NULL
I	NULL
1	NULL
o	NULL
o	NULL
g	NULL
o	NULL
o	NULL
o	NULL
o	NULL
g	NULL
o	NULL
g	NULL
-	NULL
2	NULL
2	NULL
§	NULL
2	NULL
2	NULL
2	NULL
2	NULL
2	NULL
2	NULL
2	NULL
conc	NULL
(	NULL
ng/m	NULL
!	NULL
)	NULL

|	NULL
we	NULL
©	NULL
150	NULL
15	NULL
15	NULL
15	NULL
15	NULL
150	NULL
1	NULL
5	NULL
15	NULL
30	NULL
90	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
a-	NULL
A	NULL
v*	NULL
mil	NULL
4	NULL
Lq	NULL
(	NULL
Free	NULL
Probe	NULL
1°	NULL
2	NULL
3	NULL
4	NULL
50	NULL
60	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
FIGURE	NULL
3	NULL
.	NULL

Dose	NULL
and	NULL
time-dependence	NULL
of	NULL
IL-13-induced	NULL
Ce	NULL
DNA-protein-binding	NULL
complexes	NULL
in	NULL
primary	NULL
T	NULL
cells	NULL
.	NULL

Primary	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
medium	NULL
as	NULL
control	NULL
(	NULL
CTRL	NULL
)	NULL
,	NULL
1	NULL
,	NULL
10	NULL
,	NULL
100	NULL
,	NULL
500	NULL
,	NULL
1,000	NULL
ng/m	NULL
!	NULL

of	NULL
IL-13	NULL
for	NULL
15	NULL
min	NULL
(	NULL
Zanes	NULL
1-6	NULL
)	NULL
,	NULL
100	NULL
ng/ml	NULL
IL-4	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
or	NULL
with	NULL
100	NULL
ng/ml	NULL
IL-13	NULL
for	NULL
1	NULL
,	NULL
5	NULL
,	NULL
15	NULL
,	NULL
30	NULL
,	NULL
and	NULL
90	NULL
min	NULL
(	NULL
lanes	NULL
8-12	NULL
)	NULL
.	NULL

Ten	NULL
micrograms	NULL
of	NULL
nuclear	NULL
proteins	NULL
were	NULL
used	NULL
for	NULL
EMSA	NULL
using	NULL
a	NULL
*°P-labeled	NULL
Ce	NULL
GAS	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

Arrows	NULL
A	NULL
and	NULL
B	NULL
denote	NULL
DNA-protein	NULL
complexes	NULL
A	NULL
and	NULL
B	NULL
.	NULL

Bracket	NULL
indicates	NULL
a	NULL
free	NULL
°°P-labeled	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

complexes	NULL
further	NULL
suggests	NULL
that	NULL
primary	NULL
human	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
express	NULL
functional	NULL
IL-13R	NULL
.	NULL

Second	NULL
,	NULL
IL-13	NULL
and	NULL
IL-4	NULL
induce	NULL
similar	NULL
binding	NULL
complexes	NULL
in	NULL
NK	NULL
or	NULL
T	NULL
cells	NULL
.	NULL

Third	NULL
,	NULL
distinct	NULL
DNA-protein	NULL
binding	NULL
complexes	NULL
are	NULL
induced	NULL
by	NULL
IL-13	NULL
and	NULL
IL-4	NULL
,	NULL
when	NULL
comparing	NULL
both	NULL
cell	NULL
types	NULL
.	NULL

It	NULL
is	NULL
well	NULL
established	NULL
that	NULL
STAT	NULL
proteins	NULL
show	NULL
preferential	NULL
binding	NULL
affinity	NULL
to	NULL
different	NULL
DNA-recognition	NULL
sequences	NULL
(	NULL
31	NULL
,	NULL
58	NULL
)	NULL
.	NULL

To	NULL
explore	NULL
the	NULL
possibility	NULL
that	NULL
IL-13	NULL
and	NULL
IL-4	NULL
induce	NULL
distinct	NULL
DNA-binding	NULL
complexes	NULL
when	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
are	NULL
compared	NULL
,	NULL
we	NULL
analyzed	NULL
these	NULL
cells	NULL
using	NULL
a	NULL
SIE	NULL
GAS-like	NULL
oligonucleotide	NULL
probe	NULL
that	NULL
preferentially	NULL
binds	NULL
STAT1a	NULL
,	NULL
STAT3	NULL
,	NULL
and	NULL
STAT4	NULL
(	NULL
induced	NULL
by	NULL
IL-6	NULL
and	NULL
IL-12	NULL
,	NULL
respectively	NULL
)	NULL
(	NULL
49	NULL
,	NULL
52	NULL
,	NULL
59	NULL
,	NULL
60	NULL
)	NULL
.	NULL

IL-13	NULL
and	NULL
IL-4	NULL
did	NULL
not	NULL
induce	NULL
DNA-protein	NULL
complex	NULL
formation	NULL
with	NULL
its	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
3	NULL
,	NULL
4	NULL
,	NULL
7	NULL
,	NULL
and	NULL
8	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IL-6	NULL
induced	NULL
three	NULL
SIE	NULL
GAS	NULL
DNA-protein-binding	NULL
complexes	NULL
with	NULL
similar	NULL
mobility	NULL
(	NULL
Zanes	NULL
2	NULL
and	NULL
7	NULL
)	NULL
when	NULL
comparing	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
,	NULL
while	NULL
IL-12	NULL
induces	NULL
two	NULL
unique	NULL
bands	NULL
upon	NULL
prolonged	NULL
exposure	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
different	NULL
GAS-like	NULL
element	NULL
DNA	NULL
probes	NULL
(	NULL
ie	NULL
,	NULL
Ce	NULL
or	NULL
SIE	NULL
)	NULL
can	NULL
selectively	NULL
bind	NULL
activated	NULL
STAT	NULL
proteins	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
unique	NULL
binding	NULL
patterns	NULL
.	NULL

Moreover	NULL
,	NULL
these	NULL
data	NULL
also	NULL
suggest	NULL
that	NULL
IL-13	NULL
and	NULL
IL-4	NULL
might	NULL
not	NULL
significantly	NULL
induce	NULL
the	NULL
activation	NULL
of	NULL
STAT1a	NULL
«	NULL
and	NULL
STAT3	NULL
proteins	NULL
in	NULL
primary	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

Dose	NULL
and	NULL
time-dependence	NULL
of	NULL
IL-13-induced	NULL
Ce	NULL
DNA-protein-binding	NULL
complexes	NULL
To	NULL
further	NULL
characterize	NULL
IL-13	NULL
activation	NULL
of	NULL
STAT6	NULL
in	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
,	NULL
time-course	NULL
and	NULL
dose-dependence	NULL
assays	NULL
were	NULL
performed	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
with	NULL
1	NULL
,	NULL
10	NULL
,	NULL
100	NULL
,	NULL
500	NULL
,	NULL
or	NULL
1,000	NULL
ng/ml	NULL
of	NULL
IL-13	NULL
for	NULL
15	NULL
min	NULL
or	NULL
with	NULL
100	NULL
ng/ml	NULL
of	NULL
IL-13	NULL
for	NULL
1	NULL
,	NULL
5	NULL
,	NULL
15	NULL
,	NULL
30	NULL
,	NULL
and	NULL
90	NULL
min	NULL
for	NULL
EMSA	NULL
assay	NULL
,	NULL
or	NULL
with	NULL
100	NULL
ng/ml	NULL
of	NULL
IL-4	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

IL-13	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

very	NULL
weakly	NULL
induced	NULL
Ce	NULL
DNA-protein-binding	NULL
complexes	NULL
while	NULL
100	NULL
(	NULL
8	NULL
nM	NULL
)	NULL
,	NULL
500	NULL
,	NULL
and	NULL
1000	NULL
ng/ml	NULL
of	NULL
IL-13	NULL
induced	NULL
two	NULL
Ce	NULL
DNA-protein-binding	NULL
complexes	NULL
(	NULL
designat-	NULL
EFFECTS	NULL
OF	NULL
IL-13	NULL
ON	NULL
NK	NULL
AND	NULL
T	NULL
CELLS	NULL
ed	NULL
as	NULL
complexes	NULL
A	NULL
and	NULL
B	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lanes	NULL
4	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Peak	NULL
induction	NULL
of	NULL
Ce	NULL
DNA-protein-binding	NULL
complexes	NULL
was	NULL
found	NULL
to	NULL
occur	NULL
between	NULL
15	NULL
and	NULL
30	NULL
min	NULL
(	NULL
Zanes	NULL
10	NULL
and	NULL
11	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
similar	NULL
to	NULL
those	NULL
observed	NULL
with	NULL
IL-4	NULL
induction	NULL
of	NULL
IL-4NAF-binding	NULL
complexes	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Lastly	NULL
,	NULL
100	NULL
ng/ml	NULL
of	NULL
IL-4	NULL
induced	NULL
the	NULL
same	NULL
complexes	NULL
that	NULL
were	NULL
induced	NULL
by	NULL
IL-13	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

IL-13-induced	NULL
Ce	NULL
DNA-protein	NULL
complexes	NULL
contain	NULL
STAT6	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
To	NULL
identify	NULL
the	NULL
protein	NULL
components	NULL
in	NULL
IL-13-	NULL
and	NULL
IL-4-induced	NULL
Ce	NULL
DNA-binding	NULL
complexes	NULL
,	NULL
supershift	NULL
analysis	NULL
with	NULL
STAT6-specific	NULL
Abs	NULL
was	NULL
performed	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Three	NULL
anti-STAT6	NULL
antisera	NULL
were	NULL
tested	NULL
,	NULL
which	NULL
recognize	NULL
distinct	NULL
STAT6	NULL
sites	NULL
(	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

In	NULL
the	NULL
IL-13-treated	NULL
nuclear	NULL
extracts	NULL
,	NULL
Ab	NULL
prepared	NULL
against	NULL
amino	NULL
acids	NULL
827-847	NULL
(	NULL
designated	NULL
STAT6h1	NULL
)	NULL
effectively	NULL
blocked	NULL
and	NULL
supershifted	NULL
both	NULL
complexes	NULL
A	NULL
and	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
other	NULL
Ab	NULL
recognizing	NULL
amino	NULL
acids	NULL
787-804	NULL
(	NULL
designated	NULL
STATh2	NULL
)	NULL
blocked	NULL
and	NULL
supershifted	NULL
only	NULL
complex	NULL
A	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
antisera	NULL
against	NULL
STAT3	NULL
and	NULL
STATém	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
these	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
complexes	NULL
A	NULL
and	NULL
B	NULL
contain	NULL
STAT6	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
.	NULL

Whether	NULL
Ab	NULL
prepared	NULL
against	NULL
amino	NULL
acids	NULL
787-804	NULL
is	NULL
less	NULL
efficient	NULL
or	NULL
incapable	NULL
of	NULL
recognizing	NULL
possible	NULL
STAT6	NULL
isoforms	NULL
or	NULL
other	NULL
associated	NULL
protein	NULL
involvement	NULL
is	NULL
unknown	NULL
.	NULL

Similar	NULL
supershift	NULL
results	NULL
also	NULL
were	NULL
obtained	NULL
in	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
IL-4-treated	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Complexes	NULL
A	NULL
and	NULL
B	NULL
induced	NULL
by	NULL
IL-4	NULL
contained	NULL
STAT6	NULL
proteins	NULL
,	NULL
but	NULL
not	NULL
STAT3	NULL
and	NULL
STAT4	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
5	NULL
)	NULL
,	NULL
or	NULL
STATS5a	NULL
and	NULL
STAT5b	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Western	NULL
STAT6	NULL
supershift	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
NK	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
demonstrated	NULL
that	NULL
IL-13	NULL
is	NULL
able	NULL
to	NULL
directly	NULL
activate	NULL
STAT6	NULL
in	NULL
fresh	NULL
primary	NULL
T	NULL
and	NULL
NK	NULL
cells	NULL
,	NULL
analogous	NULL
to	NULL
IL-4	NULL
.	NULL

IL-13	NULL
induces	NULL
different	NULL
patterns	NULL
of	NULL
Ce	NULL
DNA-protein-binding	NULL
complexes	NULL
in	NULL
preactivated	NULL
primary	NULL
T	NULL
cells	NULL
vs	NULL
fresh	NULL
primary	NULL
T	NULL
cells	NULL
The	NULL
activation	NULL
of	NULL
primary	NULL
T	NULL
cells	NULL
for	NULL
several	NULL
days	NULL
by	NULL
various	NULL
stim-uli	NULL
,	NULL
such	NULL
as	NULL
IL-2	NULL
,	NULL
anti-CD3	NULL
Ab	NULL
,	NULL
or	NULL
PHA	NULL
,	NULL
leads	NULL
to	NULL
morphologic	NULL
and	NULL
functional	NULL
cell	NULL
changes	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
preactivated	NULL
T	NULL
cells	NULL
,	NULL
stimulated	NULL
with	NULL
PHA/IL-2	NULL
for	NULL
3	NULL
days	NULL
(	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
,	NULL
are	NULL
distinct	NULL
from	NULL
the	NULL
freshly	NULL
isolated	NULL
primary	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
IL-4	NULL
or	NULL
IL-13	NULL
,	NULL
STAT6	NULL
activation	NULL
was	NULL
measured	NULL
by	NULL
EMSA	NULL
,	NULL
and	NULL
supershift	NULL
analysis	NULL
was	NULL
performed	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

In	NULL
both	NULL
primary	NULL
(	NULL
Zane	NULL
1-3	NULL
)	NULL
and	NULL
preactivated	NULL
T	NULL
cells	NULL
(	NULL
lanes	NULL
4-12	NULL
)	NULL
obtained	NULL
from	NULL
the	NULL
same	NULL
donor	NULL
,	NULL
IL-4	NULL
and	NULL
IL-13	NULL
induced	NULL
complex	NULL
A	NULL
and	NULL
B	NULL
in	NULL
primary	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
(	NULL
see	NULL
also	NULL
Figs	NULL
.	NULL

2	NULL
and	NULL
3	NULL
)	NULL
while	NULL
significantly	NULL
inducing	NULL
three	NULL
Ce	NULL
DNA-protein-binding	NULL
complexes	NULL
(	NULL
designated	NULL
as	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
)	NULL
in	NULL
the	NULL
preactivated	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
observed	NULL
in	NULL
three	NULL
other	NULL
donors	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

IL-2	NULL
did	NULL
not	NULL
induce	NULL
any	NULL
DNA-protein	NULL
complex	NULL
in	NULL
this	NULL
donor	NULL
's	NULL
cells	NULL
,	NULL
but	NULL
a	NULL
single	NULL
band	NULL
,	NULL
more	NULL
slowly	NULL
migrating	NULL
than	NULL
the	NULL
bands	NULL
induced	NULL
by	NULL
IL-13	NULL
or	NULL
IL-4	NULL
,	NULL
was	NULL
seen	NULL
with	NULL
cells	NULL
obtained	NULL
from	NULL
other	NULL
donors	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
supershift	NULL
analysis	NULL
showed	NULL
that	NULL
both	NULL
complex	NULL
A	NULL
and	NULL
complex	NULL
B	NULL
were	NULL
blocked	NULL
with	NULL
anti-STAT6h1	NULL
antiserum	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
while	NULL
only	NULL
complex	NULL
A	NULL
was	NULL
blocked	NULL
by	NULL
anti-STAT6h2	NULL
antiserum	NULL
for	NULL
IL-13-	NULL
and	NULL
IL-4-treated	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
result	NULL
is	NULL
consistent	NULL
with	NULL
results	NULL
described	NULL
in	NULL
Figure	NULL
4	NULL
.	NULL

However	NULL
,	NULL
complex	NULL
C	NULL
was	NULL
neither	NULL
blocked	NULL
nor	NULL
supershifted	NULL
by	NULL
anti-STAT1	NULL
a	NULL
,	NULL
-STAT3	NULL
,	NULL
-STAT4	NULL
,	NULL
or	NULL
-STAT5	NULL
@	NULL
/b	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
8	NULL
,	NULL
9	NULL
,	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
elucidate	NULL
the	NULL
identity	NULL
of	NULL
complex	NULL
C	NULL
,	NULL
specific	NULL
and	NULL
nonspecific	NULL
cold	NULL
oligo	NULL
competition	NULL
assays	NULL
within	NULL
EMSA	NULL
were	NULL
performed	NULL
.	NULL

Complex	NULL
C	NULL
,	NULL
as	NULL
well	NULL
as	NULL
complexes	NULL
A	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
223	NULL
A	NULL
B	NULL
Primary	NULL
T	NULL
Cells	NULL
Primary	NULL
T	NULL
Cells	NULL
IL-13	NULL
+	NULL
O+	NULL
4+	NULL
+	NULL
+	NULL
IL-4	NULL
_+	NULL
4	NULL
+	NULL
+	NULL
+	NULL
#	NULL
+	NULL
v=	NULL
N	NULL
w	NULL
€§	NULL
&	NULL
&	NULL
o	NULL
x	NULL
&	NULL
&	NULL
8	NULL
wad	NULL
«	NULL
l	NULL
FIGURE	NULL
4	NULL
.	NULL

IL-13-induced	NULL
Ce	NULL
DNA-protein	NULL
c	NULL
k	NULL
&	NULL
4	NULL
&	NULL
z	NULL
4	NULL
4	NULL
&	NULL
&	NULL
4	NULL
complexes	NULL
contain	NULL
STAT6	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
.	NULL

A	NULL
,	NULL
Ten	NULL
micro-	NULL
Abs	NULL
E3	NULL
5	NULL
5	NULL
5	NULL
5	NULL
Abs	NULL
5	NULL
5	NULL
E	NULL
E75	NULL
5	NULL
a	NULL
;	NULL
grams	NULL
of	NULL
nuclear	NULL
proteins	NULL
prepared	NULL
from	NULL
fresh	NULL
pri-	NULL
tm	NULL
mary	NULL
T	NULL
cells	NULL
treated	NULL
by	NULL
IL-13	NULL
(	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

e	NULL
SP	NULL
'	NULL
'	NULL
was	NULL
used	NULL
for	NULL
EMSA	NULL
supershift	NULL
analysis	NULL
using	NULL
a	NULL
*°P-labeled	NULL
Ce	NULL
GAS	NULL
oligonucleotide	NULL
probe	NULL
with	NULL
antisera	NULL
w	NULL
H	NULL
toad	NULL
112	NULL
“	NULL
uH	NULL
t	NULL
P	NULL
``	NULL
ﬂ	NULL
B	NULL
against	NULL
STAT3	NULL
,	NULL
STAT6h1	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
STAT6m	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
and	NULL
STAT6h2	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
.	NULL

B	NULL
,	NULL
Supershift	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
nuclear	NULL
proteins	NULL
prepared	NULL
from	NULL
IL-4-treated	NULL
fresh	NULL
primary	NULL
T	NULL
cells	NULL
(	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
with	NULL
antisera	NULL
against	NULL
STAT3	NULL
,	NULL
STAT4	NULL
,	NULL
t	NULL
¥	NULL
!	NULL

(	NULL
4	NULL
|	NULL
I1	NULL
1	NULL
‘	NULL
l	NULL
STAT6h1	NULL
,	NULL
STAT6m	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
,	NULL
and	NULL
STAT6h1	NULL
(	NULL
lane	NULL
|	NULL
6	NULL
)	NULL
.	NULL

Arrows	NULL
A	NULL
and	NULL
B	NULL
denote	NULL
DNA-protein	NULL
complexes	NULL
A	NULL
and	NULL
B	NULL
while	NULL
SP	NULL
indicates	NULL
supershifted	NULL
complexes	NULL
.	NULL

Bracket	NULL
indicates	NULL
free	NULL
*°P-labeled	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

Free	NULL
Probe	NULL
Free	NULL
Probe	NULL
1°	NULL
20	NULL
3	NULL
4	NULL
5	NULL
1°	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
and	NULL
B	NULL
,	NULL
was	NULL
completely	NULL
competed	NULL
with	NULL
1	NULL
ng	NULL
of	NULL
specific	NULL
cold	NULL
Ce	NULL
suggest	NULL
that	NULL
IL-13	NULL
and	NULL
IL-4	NULL
might	NULL
induce	NULL
different	NULL
patterns	NULL
of	NULL
oligonucleotides	NULL
but	NULL
not	NULL
with	NULL
1	NULL
ng	NULL
SIE	NULL
or	NULL
mutated	NULL
oligos	NULL
,	NULL
sug-	NULL
STAT6	NULL
activation	NULL
when	NULL
comparing	NULL
preactivated	NULL
and	NULL
fresh	NULL
pri-gesting	NULL
that	NULL
complex	NULL
C	NULL
is	NULL
a	NULL
specific	NULL
one	NULL
.	NULL

Therefore	NULL
,	NULL
complex	NULL
C	NULL
mary	NULL
T	NULL
cells	NULL
and	NULL
further	NULL
suggest	NULL
that	NULL
STAT6	NULL
might	NULL
be	NULL
differ-may	NULL
be	NULL
specific	NULL
for	NULL
preactivated	NULL
primary	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
data	NULL
entially	NULL
utilized	NULL
in	NULL
various	NULL
T	NULL
cell	NULL
types	NULL
.	NULL

Primary	NULL
T	NULL
cells	NULL
Preactivated	NULL
T	NULL
cells	NULL
I	NULL
1	NULL
of	NULL
[	NULL
IL-4	NULL
-o	NULL
ge	NULL
0	NULL
-	NULL
-	NULL
#	NULL
00	NULL
_	NULL
o_	NULL
o_	NULL
&	NULL
o_	NULL
o_	NULL
04	NULL
IL-13	NULL
-	NULL
0	NULL
-	NULL
#	NULL
00	NULL
-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+0	NULL
+	NULL
+0	NULL
+	NULL
>	NULL
16	NULL
aC	NULL
a	NULL
»	NULL
Abs	NULL
Lo	NULL
_	NULL
_	NULL
_	NULL
_	NULL
_	NULL
f	NULL
&	NULL
egg	NULL
“	NULL
_	NULL
Lo	NULL
cold	NULL
oligoes	NULL
orr	NULL
2	NULL
#	NULL
a	NULL
FIGURE	NULL
5	NULL
.	NULL

IL-13	NULL
induces	NULL
different	NULL
patterns	NULL
of	NULL
Ce	NULL
DNA-protein-binding	NULL
complexes	NULL
with	NULL
primary	NULL
t	NULL
freshly	NULL
isolated	NULL
(	NULL
Zanes	NULL
1-3	NULL
)	NULL
and	NULL
preeilctivated	NULL
primary	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
anes	NULL
4-12	NULL
)	NULL
.	NULL

Nuclear	NULL
proteins	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
were	NULL
u	NULL
u	NULL
“	NULL
H	NULL
H.	NULL
<	NULL
-	NULL
A	NULL
prepared	NULL
from	NULL
primary	NULL
and	NULL
preactivated	NULL
T	NULL
cells	NULL
that	NULL
to	NULL
4	NULL
-	NULL
*-	NULL
B	NULL
had	NULL
been	NULL
treated	NULL
with	NULL
medium	NULL
(	NULL
Zanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
,	NULL
IL-4	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
,	NULL
or	NULL
IL-13	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
6-12	NULL
)	NULL
,	NULL
as	NULL
de	NULL
A	NULL
scribed	NULL
in	NULL
Figure	NULL
2	NULL
.	NULL

STAT	NULL
activation	NULL
was	NULL
examined	NULL
A	NULL
i	NULL
by	NULL
EMSA	NULL
using	NULL
a	NULL
*°P-labeled	NULL
Ce	NULL
GAS	NULL
oligonucleo-	NULL
tide	NULL
probe	NULL
.	NULL

Cold	NULL
oligonucleotide	NULL
competition	NULL
assays	NULL
{	NULL
were	NULL
performed	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
nuclear	NULL
proteins	NULL
pre-	NULL
l	NULL
‘	NULL
®	NULL
pared	NULL
from	NULL
IL-13-treated	NULL
(	NULL
Zanes	NULL
6-12	NULL
)	NULL
preactivated	NULL
T	NULL
cells	NULL
with	NULL
antisera	NULL
against	NULL
STAT6hl	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
STATla	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
,	NULL
STAT3	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
,	NULL
cold	NULL
Ce-	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
,	NULL
cold	NULL
SIE-	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
,	NULL
or	NULL
mutated	NULL
Ce	NULL
oligo	NULL
(	NULL
lane	NULL
12	NULL
)	NULL
.	NULL

Arrow	NULL
SP	NULL
indicates	NULL
supershifted	NULL
complexes	NULL
.	NULL

Bracket	NULL
indicates	NULL
free	NULL
*°P-labeled	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

Free	NULL
Probe	NULL
10	NULL
20	NULL
3	NULL
4	NULL
5	NULL
60	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
224	NULL
FIGURE	NULL
6	NULL
.	NULL

IL-13	NULL
induces	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT6	NULL
in	NULL
primary	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
Cell	NULL
lysates	NULL
from	NULL
6	NULL
X	NULL
10	NULL
``	NULL
NK	NULL
(	NULL
lanes	NULL
1-3	NULL
)	NULL
or	NULL
T	NULL
cells	NULL
(	NULL
lanes	NULL
4-6	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
medium	NULL
as	NULL
control	NULL
(	NULL
CTRL	NULL
)	NULL
,	NULL
IL-4	NULL
or	NULL
IL-13	NULL
(	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
anti-STAT6	NULL
antisera	NULL
.	NULL

Immunoprecipitated	NULL
protein	NULL
was	NULL
blotted	NULL
with	NULL
the	NULL
anti-phophotyrosine	NULL
Ab	NULL
,	NULL
4G10	NULL
.	NULL

Arrow	NULL
denotes	NULL
phosphorylated	NULL
STAT6	NULL
,	NULL
pSTAT6	NULL
.	NULL

B	NULL
,	NULL
The	NULL
blot	NULL
was	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
anti-STAT6	NULL
antiserum	NULL
.	NULL

Arrow	NULL
denotes	NULL
STAT6	NULL
proteins	NULL
.	NULL

Bracket	NULL
indicates	NULL
Ig	NULL
heavy	NULL
chain	NULL
(	NULL
IgG	NULL
HC	NULL
)	NULL
.	NULL

Molecular	NULL
size	NULL
markers	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
side	NULL
.	NULL

NK	NULL
Cells	NULL
Peon	NULL
IL-4	NULL
-	NULL
040	NULL
-	NULL
IL-13	NULL
-	NULL
-	NULL
+	NULL
~	NULL
»	NULL
<	NULL
up	NULL
comp	NULL
mGHC	NULL
[	NULL
IL-13	NULL
induces	NULL
activation	NULL
of	NULL
STAT6	NULL
via	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT6	NULL
and	NULL
JAK3	NULL
To	NULL
determine	NULL
whether	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT6	NULL
occurs	NULL
following	NULL
IL-13-treatment	NULL
in	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
analyzed	NULL
lysates	NULL
of	NULL
stimulated	NULL
cells	NULL
with	NULL
anti-STAT6	NULL
antiserum	NULL
via	NULL
immunoprecipitation	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Anti-phosphotyrosine	NULL
Western	NULL
blotting	NULL
revealed	NULL
that	NULL
STAT6	NULL
was	NULL
phosphorylated	NULL
following	NULL
IL-13	NULL
stimulation	NULL
in	NULL
NK	NULL
cells	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
and	NULL
T	NULL
cells	NULL
(	NULL
Zane	NULL
6	NULL
)	NULL
in	NULL
a	NULL
manner	NULL
analogous	NULL
to	NULL
IL-4-treated	NULL
cells	NULL
(	NULL
Zanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
.	NULL

This	NULL
blot	NULL
was	NULL
then	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
anti-STAT6	NULL
antiserum	NULL
to	NULL
verify	NULL
equal	NULL
amounts	NULL
of	NULL
loaded	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

A	NULL
small	NULL
fragment	NULL
migrating	NULL
with	NULL
an	NULL
apparent	NULL
molecular	NULL
mass	NULL
of	NULL
100	NULL
kDa	NULL
also	NULL
was	NULL
recognized	NULL
by	NULL
the	NULL
anti-STAT6	NULL
antiserum	NULL
although	NULL
it	NULL
was	NULL
not	NULL
detected	NULL
with	NULL
anti-phosphotyrosine	NULL
Ab	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

Whether	NULL
this	NULL
protein	NULL
represents	NULL
an	NULL
isoform	NULL
of	NULL
STAT6	NULL
or	NULL
a	NULL
degraded	NULL
product	NULL
is	NULL
currently	NULL
being	NULL
investigated	NULL
.	NULL

In	NULL
any	NULL
case	NULL
,	NULL
these	NULL
results	NULL
demonstrate	NULL
that	NULL
IL-13	NULL
,	NULL
as	NULL
well	NULL
as	NULL
IL-4	NULL
,	NULL
induce	NULL
STAT6	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
IL-13	NULL
,	NULL
like	NULL
IL-4	NULL
,	NULL
is	NULL
able	NULL
to	NULL
induce	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK3	NULL
and	NULL
JAK1	NULL
in	NULL
primary	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
immunoprecipitation	NULL
assays	NULL
of	NULL
JAK3	NULL
and	NULL
JAK1	NULL
were	NULL
performed	NULL
with	NULL
extracts	NULL
from	NULL
the	NULL
preactivated	NULL
primary	NULL
T	NULL
cells	NULL
that	NULL
have	NULL
been	NULL
stimulated	NULL
with	NULL
medium	NULL
,	NULL
100	NULL
ng/m	NULL
!	NULL

of	NULL
IL-13	NULL
,	NULL
and	NULL
100	NULL
ng/ml	NULL
of	NULL
IL-4	NULL
for	NULL
15	NULL
min	NULL
respectively	NULL
.	NULL

The	NULL
results	NULL
showed	NULL
that	NULL
IL-13	NULL
induces	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK3	NULL
although	NULL
the	NULL
level	NULL
of	NULL
IL-13-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK3	NULL
was	NULL
lower	NULL
than	NULL
induced	NULL
by	NULL
IL-4	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
comparison	NULL
with	NULL
JAK3	NULL
,	NULL
IL-13	NULL
very	NULL
weakly	NULL
induced	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
IL-13	NULL
induced	NULL
the	NULL
activation	NULL
of	NULL
STAT6	NULL
,	NULL
due	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
JAK3	NULL
.	NULL

Discussion	NULL
In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
IL-13	NULL
and	NULL
IL-4	NULL
differentially	NULL
regulate	NULL
specific	NULL
functional	NULL
activities	NULL
of	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
provide	NULL
evidence	NULL
that	NULL
IL-13	NULL
,	NULL
similar	NULL
to	NULL
IL-4	NULL
,	NULL
induces	NULL
the	NULL
activation	NULL
of	NULL
STAT6	NULL
and	NULL
JAK3	NULL
in	NULL
fresh	NULL
primary	NULL
T	NULL
and	NULL
NK	NULL
cells	NULL
.	NULL

This	NULL
conclusion	NULL
is	NULL
based	NULL
on	NULL
EMSA	NULL
,	NULL
supershift	NULL
analysis	NULL
,	NULL
immunopre-cipitation	NULL
,	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
found	NULL
that	NULL
IL-13	NULL
,	NULL
as	NULL
well	NULL
as	NULL
IL-4	NULL
,	NULL
induced	NULL
distinct	NULL
and	NULL
overlapping	NULL
patterns	NULL
of	NULL
Ce	NULL
DNA-protein-binding	NULL
complexes	NULL
when	NULL
comparing	NULL
primary	NULL
NK	NULL
cells	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
STAT6	NULL
may	NULL
be	NULL
differentially	NULL
utilized	NULL
in	NULL
a	NULL
cell-dependent	NULL
fashion	NULL
and	NULL
that	NULL
IL-13	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

We	NULL
have	NULL
observed	NULL
that	NULL
IL-13	NULL
,	NULL
but	NULL
not	NULL
IL-4	NULL
,	NULL
weakly	NULL
induced	NULL
IFN-y	NULL
production	NULL
in	NULL
NK	NULL
cells	NULL
and	NULL
either	NULL
synergized	NULL
with	NULL
IL-2	NULL
or	NULL
weakly	NULL
inhibited	NULL
(	NULL
with	NULL
30-50	NULL
%	NULL
reduction	NULL
)	NULL
IL-2-mediated	NULL
IFN-y	NULL
T	NULL
Cells	NULL
NK	NULL
Cells	NULL
T	NULL
Cells	NULL
F	NULL
--	NULL
-	NULL
O	NULL
EFFECTS	NULL
OF	NULL
IL-13	NULL
ON	NULL
NK	NULL
AND	NULL
T	NULL
CELLS	NULL
[	NULL
OI	NULL
IL-4	NULL
-	NULL
0	NULL
400-0	NULL
o-	NULL
#	NULL
0	NULL
IL-18	NULL
-	NULL
-	NULL
£0	NULL
-	NULL
-	NULL
+	NULL
4	NULL
Marker	NULL
Marker	NULL
-	NULL
+	NULL
kDa	NULL
kDa	NULL
-116	NULL
_	NULL
STATG-	NULL
»	NULL
>	NULL
aas	NULL
ame	NULL
amp	NULL
«	NULL
e	NULL
ase	NULL
ame	NULL
__	NULL
~-	NULL
115	NULL
-or	NULL
e	NULL
-97	NULL
-66	NULL
-66	NULL
-as	NULL
-	NULL
too	NULL
#	NULL
Cl	NULL
C	NULL
oan	NULL
ae	NULL
w	NULL
aHe	NULL
=	NULL
-	NULL
:	NULL
production	NULL
.	NULL

This	NULL
result	NULL
likely	NULL
reflects	NULL
the	NULL
variability	NULL
in	NULL
NK	NULL
cells	NULL
seen	NULL
from	NULL
donor	NULL
to	NULL
donor	NULL
.	NULL

However	NULL
,	NULL
in	NULL
both	NULL
situations	NULL
,	NULL
the	NULL
IL-13	NULL
effect	NULL
was	NULL
in	NULL
marked	NULL
contrast	NULL
to	NULL
the	NULL
strong	NULL
inhibition	NULL
(	NULL
with	NULL
more	NULL
than	NULL
90	NULL
%	NULL
reduction	NULL
)	NULL
seen	NULL
with	NULL
IL-4	NULL
in	NULL
NK	NULL
cells	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

The	NULL
different	NULL
effects	NULL
of	NULL
IL-13	NULL
and	NULL
IL-4	NULL
on	NULL
IFN-y	NULL
production	NULL
in	NULL
NK	NULL
cells	NULL
also	NULL
were	NULL
confirmed	NULL
by	NULL
analyzing	NULL
the	NULL
effects	NULL
of	NULL
IL-4	NULL
and	NULL
IL-13	NULL
pretreatment	NULL
for	NULL
the	NULL
first	NULL
24	NULL
h	NULL
on	NULL
IL-2-mediated	NULL
IFN-y	NULL
production	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
IL-13	NULL
and	NULL
IL-4	NULL
might	NULL
have	NULL
a	NULL
different	NULL
role	NULL
in	NULL
regulating	NULL
IFN-y	NULL
production	NULL
in	NULL
NK	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
IL-13	NULL
and	NULL
IL-4	NULL
similarly	NULL
inhibit	NULL
PHA-induced	NULL
IFN-y	NULL
secretion	NULL
.	NULL

This	NULL
is	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
effect	NULL
of	NULL
IL-4	NULL
on	NULL
NK	NULL
cells	NULL
where	NULL
it	NULL
acts	NULL
as	NULL
a	NULL
strong	NULL
inhibitor	NULL
of	NULL
IFN-y	NULL
production	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
NK	NULL
cells	NULL
,	NULL
IL-13	NULL
weakly	NULL
and	NULL
IL-4	NULL
strongly	NULL
inhibit	NULL
the	NULL
IL-2-induced	NULL
cytolytic	NULL
activities	NULL
whereas	NULL
,	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
both	NULL
IL-13	NULL
and	NULL
IL-4	NULL
enhance	NULL
CD3/IL-2-mediated	NULL
LAK	NULL
potential	NULL
.	NULL

These	NULL
data	NULL
also	NULL
suggest	NULL
that	NULL
T	NULL
cells	NULL
express	NULL
functional	NULL
IL-13R	NULL
and	NULL
IL-13	NULL
might	NULL
share	NULL
similar	NULL
biologic	NULL
effects	NULL
with	NULL
IL-4	NULL
in	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
previous	NULL
report	NULL
has	NULL
demonstrated	NULL
that	NULL
IL-13	NULL
was	NULL
able	NULL
to	NULL
increase	NULL
IL-2-mediated	NULL
LAK	NULL
activity	NULL
,	NULL
while	NULL
our	NULL
data	NULL
demonstrated	NULL
IL-13	NULL
weakly	NULL
inhibits	NULL
this	NULL
activity	NULL
.	NULL

The	NULL
discrepancy	NULL
in	NULL
these	NULL
findings	NULL
may	NULL
be	NULL
due	NULL
to	NULL
donor	NULL
differences	NULL
or	NULL
the	NULL
different	NULL
sources	NULL
of	NULL
IL-13	NULL
used	NULL
T	NULL
cells	NULL
T	NULL
cells	NULL
g	NULL
-o-	NULL
x	NULL
IL-4	NULL
-o	NULL
4	NULL
o-	NULL
-o	NULL
4	NULL
-	NULL
3	NULL
IL43	NULL
20	NULL
~	NULL
oy	NULL
,	NULL
>	NULL
.	NULL

>	NULL
.	NULL

%	NULL
g	NULL
=	NULL
KDa	NULL
pJak3	NULL
Jak3	NULL
*~*	NULL
«	NULL
==	NULL
«	NULL
-	NULL
»	NULL
-	NULL
116	NULL
-	NULL
97	NULL
-	NULL
66	NULL
tit	NULL
UB	NULL
WD	NULL
}	NULL
soc	NULL
-	NULL
43	NULL
1°	NULL
203	NULL
1°	NULL
203	NULL
FIGURE	NULL
7	NULL
.	NULL

The	NULL
immunoprecipitation	NULL
assays	NULL
against	NULL
JAK3	NULL
and	NULL
JAK1	NULL
were	NULL
performed	NULL
in	NULL
the	NULL
preactivated	NULL
primary	NULL
6	NULL
X	NULL
10	NULL
``	NULL
T	NULL
cells	NULL
that	NULL
have	NULL
been	NULL
stimulated	NULL
with	NULL
medium	NULL
(	NULL
CTL	NULL
)	NULL
,	NULL
100	NULL
ng/ml	NULL
of	NULL
IL-4	NULL
,	NULL
and	NULL
100	NULL
ng/ml	NULL
of	NULL
IL-13	NULL
for	NULL
15	NULL
min	NULL
,	NULL
respectively	NULL
.	NULL

A	NULL
,	NULL
Immunoprecipitated	NULL
protein	NULL
was	NULL
blotted	NULL
by	NULL
anti-phosphotyrosine	NULL
Ab	NULL
,	NULL
4G10	NULL
.	NULL

The	NULL
arrow	NULL
denotes	NULL
phosphorylated	NULL
JAK3	NULL
,	NULL
pJAK3	NULL
.	NULL

B	NULL
,	NULL
The	NULL
blot	NULL
was	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
anti-JAK3	NULL
antiserum	NULL
.	NULL

Arrow	NULL
denotes	NULL
JAK3	NULL
proteins	NULL
.	NULL

Bracket	NULL
indicates	NULL
Ig	NULL
heavy	NULL
chain	NULL
(	NULL
IgGHC	NULL
)	NULL
.	NULL

Molecular	NULL
markers	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
in	NULL
these	NULL
studies	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
consistent	NULL
with	NULL
a	NULL
previous	NULL
report	NULL
that	NULL
IL-13	NULL
and	NULL
IL-4	NULL
have	NULL
a	NULL
different	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
LAK	NULL
activity	NULL
.	NULL

Collectively	NULL
,	NULL
this	NULL
evidence	NULL
further	NULL
elucidates	NULL
that	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
are	NULL
functionally	NULL
regulated	NULL
by	NULL
IL-13	NULL
and	NULL
that	NULL
its	NULL
effects	NULL
on	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
are	NULL
unique	NULL
and	NULL
overlapping	NULL
compared	NULL
with	NULL
IL-4	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
the	NULL
functional	NULL
IL-13R	NULL
are	NULL
not	NULL
expressed	NULL
on	NULL
T	NULL
cells	NULL
(	NULL
5	NULL
,	NULL
13-15	NULL
)	NULL
,	NULL
LAK	NULL
(	NULL
15	NULL
)	NULL
,	NULL
and	NULL
NK	NULL
cells	NULL
(	NULL
14	NULL
)	NULL
.	NULL

However	NULL
,	NULL
IL-13	NULL
,	NULL
like	NULL
IL-4	NULL
,	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
induce	NULL
IL-4	NULL
responsive	NULL
element	NULL
DNA-protein	NULL
complexes	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
16	NULL
)	NULL
or	NULL
FeyRI-binding	NULL
DNA-protein	NULL
complexes	NULL
in	NULL
fresh	NULL
human	NULL
PBL	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
a	NULL
potential	NULL
question	NULL
arises	NULL
as	NULL
to	NULL
whether	NULL
or	NULL
not	NULL
the	NULL
cells	NULL
utilized	NULL
in	NULL
the	NULL
experiments	NULL
were	NULL
contaminated	NULL
by	NULL
monocytes	NULL
or	NULL
B	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
in	NULL
the	NULL
data	NULL
presented	NULL
in	NULL
this	NULL
manuscript	NULL
,	NULL
the	NULL
primary	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
did	NULL
not	NULL
contain	NULL
a	NULL
significant	NULL
level	NULL
of	NULL
contaminating	NULL
monocytes	NULL
and	NULL
B	NULL
cells	NULL
,	NULL
based	NULL
on	NULL
fluorescent	NULL
staining	NULL
for	NULL
phenotype	NULL
determination	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
have	NULL
observed	NULL
different	NULL
patterns	NULL
of	NULL
STAT6	NULL
activation	NULL
between	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
also	NULL
could	NULL
not	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
possibility	NULL
of	NULL
monocyte	NULL
and	NULL
B	NULL
cell	NULL
contamination	NULL
in	NULL
these	NULL
cell	NULL
preparations	NULL
.	NULL

Moreover	NULL
,	NULL
IL-13	NULL
is	NULL
able	NULL
to	NULL
modulate	NULL
the	NULL
NK	NULL
and	NULL
T	NULL
cell	NULL
biologic	NULL
activities	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Thus	NULL
,	NULL
our	NULL
data	NULL
provide	NULL
evidence	NULL
that	NULL
IL-13	NULL
may	NULL
regulate	NULL
primary	NULL
T	NULL
cells	NULL
and	NULL
thereby	NULL
substitute	NULL
for	NULL
IL-4	NULL
,	NULL
perhaps	NULL
explaining	NULL
why	NULL
impairment	NULL
in	NULL
Th2	NULL
development	NULL
seen	NULL
in	NULL
STAT6	NULL
'~	NULL
mice	NULL
is	NULL
more	NULL
pronounced	NULL
than	NULL
observed	NULL
in	NULL
IL-4-defi-cient	NULL
mice	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
in	NULL
this	NULL
manuscript	NULL
,	NULL
we	NULL
have	NULL
provided	NULL
important	NULL
observations	NULL
that	NULL
offer	NULL
insight	NULL
into	NULL
the	NULL
biology	NULL
of	NULL
IL-13	NULL
and	NULL
on	NULL
the	NULL
expression	NULL
and	NULL
function	NULL
of	NULL
IL-13R	NULL
on	NULL
human	NULL
T	NULL
and	NULL
NK	NULL
cells	NULL
.	NULL

Data	NULL
from	NULL
Table	NULL
I	NULL
would	NULL
suggest	NULL
that	NULL
IL-13	NULL
is	NULL
not	NULL
a	NULL
significant	NULL
inducer	NULL
of	NULL
IFN-y	NULL
production	NULL
or	NULL
LAK	NULL
activity	NULL
for	NULL
NK	NULL
cells	NULL
,	NULL
but	NULL
perhaps	NULL
acts	NULL
as	NULL
a	NULL
co-regulatory	NULL
agent	NULL
when	NULL
combined	NULL
with	NULL
IL-2	NULL
.	NULL

Indeed	NULL
,	NULL
many	NULL
factors	NULL
regarding	NULL
NK	NULL
cell	NULL
responsiveness	NULL
to	NULL
IL-2	NULL
,	NULL
such	NULL
as	NULL
levels	NULL
and	NULL
types	NULL
of	NULL
IL-2R	NULL
expression	NULL
,	NULL
may	NULL
all	NULL
determine	NULL
differential	NULL
biologic	NULL
outcomes	NULL
following	NULL
IL-13	NULL
stimulation	NULL
.	NULL

In	NULL
the	NULL
same	NULL
donor	NULL
,	NULL
what	NULL
appears	NULL
to	NULL
be	NULL
clear	NULL
is	NULL
that	NULL
IL-13	NULL
or	NULL
IL-4	NULL
can	NULL
have	NULL
different	NULL
or	NULL
opposing	NULL
effects	NULL
on	NULL
IL-2-induced	NULL
IFN-y	NULL
production	NULL
.	NULL

Whether	NULL
these	NULL
effects	NULL
are	NULL
due	NULL
to	NULL
differences	NULL
in	NULL
unique	NULL
signal	NULL
transduction	NULL
pathways	NULL
rather	NULL
than	NULL
being	NULL
dependent	NULL
on	NULL
the	NULL
levels	NULL
of	NULL
IL-2R	NULL
expression	NULL
alone	NULL
is	NULL
not	NULL
readily	NULL
apparent	NULL
and	NULL
requires	NULL
future	NULL
study	NULL
.	NULL

It	NULL
is	NULL
known	NULL
that	NULL
the	NULL
primary	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
express	NULL
different	NULL
IL-2R	NULL
complexes	NULL
(	NULL
61	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
these	NULL
differences	NULL
may	NULL
determine	NULL
the	NULL
type	NULL
of	NULL
IL-13	NULL
effect	NULL
seen	NULL
in	NULL
NK	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
receptor	NULL
components	NULL
for	NULL
IL-13R	NULL
complex	NULL
and	NULL
its	NULL
state	NULL
of	NULL
expression	NULL
on	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
is	NULL
not	NULL
clear	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
IL-13	NULL
and	NULL
IL-4	NULL
have	NULL
overlapping	NULL
and	NULL
distinct	NULL
biologic	NULL
effects	NULL
on	NULL
both	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
IL-13	NULL
and	NULL
IL-4	NULL
are	NULL
similarly	NULL
able	NULL
to	NULL
induce	NULL
distinct	NULL
Ce	NULL
GAS	NULL
DNA-protein-binding	NULL
complexes	NULL
between	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
they	NULL
only	NULL
partially	NULL
share	NULL
similar	NULL
biologic	NULL
effects	NULL
on	NULL
IL-2-induced	NULL
proliferation	NULL
and	NULL
LAK	NULL
activity	NULL
,	NULL
but	NULL
not	NULL
IFN-y	NULL
production	NULL
in	NULL
NK	NULL
cells	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
differential	NULL
effects	NULL
of	NULL
IL-13	NULL
on	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
might	NULL
result	NULL
from	NULL
cell-dependent	NULL
signaling	NULL
pathways	NULL
,	NULL
differentiation	NULL
status	NULL
,	NULL
and	NULL
unique	NULL
cytokine-signaling	NULL
pathways	NULL
.	NULL

While	NULL
the	NULL
signaling	NULL
pathway	NULL
responsible	NULL
for	NULL
mediating	NULL
IL-13	NULL
responses	NULL
is	NULL
not	NULL
well	NULL
established	NULL
in	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
IL-4Ra	NULL
probably	NULL
serves	NULL
as	NULL
the	NULL
signaling	NULL
transducing	NULL
subunit	NULL
responsible	NULL
for	NULL
activation	NULL
of	NULL
STAT6	NULL
,	NULL
4PS	NULL
,	NULL
and	NULL
JAK1	NULL
,	NULL
as	NULL
previously	NULL
demonstrated	NULL
with	NULL
genetic	NULL
and	NULL
molecular	NULL
approaches	NULL
(	NULL
21	NULL
,	NULL
37-39	NULL
,	NULL
62	NULL
)	NULL
.	NULL

In	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
,	NULL
IL-13	NULL
induces	NULL
the	NULL
activation	NULL
of	NULL
STAT6	NULL
,	NULL
probably	NULL
via	NULL
IL-4Ra	NULL
,	NULL
that	NULL
is	NULL
also	NULL
consistent	NULL
with	NULL
the	NULL
models	NULL
where	NULL
IL-4Ra	NULL
is	NULL
able	NULL
to	NULL
associate	NULL
with	NULL
the	NULL
newly	NULL
discovered	NULL
IL-13Ra	NULL
(	NULL
28-30	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
would	NULL
be	NULL
interesting	NULL
to	NULL
determine	NULL
whether	NULL
or	NULL
not	NULL
these	NULL
IL-13Ra	NULL
(	NULL
s	NULL
)	NULL
are	NULL
differentially	NULL
distributed	NULL
between	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
in	NULL
225	NULL
the	NULL
future	NULL
study	NULL
.	NULL

A	NULL
role	NULL
for	NULL
IL-2Ry	NULL
(	NULL
or	NULL
cy	NULL
)	NULL
in	NULL
IL-13	NULL
signaling	NULL
also	NULL
has	NULL
been	NULL
suggested	NULL
based	NULL
upon	NULL
IL-13-inducible	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK3	NULL
(	NULL
21	NULL
)	NULL
and	NULL
its	NULL
association	NULL
with	NULL
IL-4Ra	NULL
«	NULL
(	NULL
63	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
IL-13	NULL
induced	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK3	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
,	NULL
although	NULL
less	NULL
effectively	NULL
than	NULL
IL-4	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
common	NULL
y	NULL
might	NULL
be	NULL
one	NULL
of	NULL
the	NULL
IL-13R	NULL
components	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
probably	NULL
in	NULL
NK	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
we	NULL
did	NULL
not	NULL
observe	NULL
a	NULL
detectable	NULL
level	NULL
of	NULL
JAK1	NULL
tyrosine	NULL
phosphorylation	NULL
although	NULL
all	NULL
proteins	NULL
are	NULL
expressed	NULL
in	NULL
equivalent	NULL
amounts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
are	NULL
in	NULL
contrast	NULL
to	NULL
a	NULL
previous	NULL
report	NULL
that	NULL
showed	NULL
IL-13	NULL
induced	NULL
JAK	NULL
1	NULL
tyrosine	NULL
phosphor-ylation	NULL
,	NULL
but	NULL
not	NULL
JAK3	NULL
,	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
(	NULL
62	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
distinct	NULL
patterns	NULL
of	NULL
IL-13	NULL
and	NULL
IL-4	NULL
signaling	NULL
may	NULL
be	NULL
observed	NULL
within	NULL
different	NULL
cell	NULL
types	NULL
although	NULL
they	NULL
may	NULL
share	NULL
only	NULL
the	NULL
common	NULL
signaling	NULL
chain	NULL
,	NULL
IL-4Ra	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
hypothesis	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
IL-13	NULL
,	NULL
as	NULL
well	NULL
as	NULL
IL-4	NULL
,	NULL
distinctively	NULL
induces	NULL
cell-specific	NULL
patterns	NULL
of	NULL
Ce	NULL
GAS	NULL
DNA-protein-binding	NULL
complexes	NULL
between	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
reported	NULL
the	NULL
existence	NULL
of	NULL
alternatively	NULL
spliced	NULL
forms	NULL
of	NULL
STAT	NULL
proteins	NULL
such	NULL
as	NULL
STAT1a	NULL
and	NULL
STAT18	NULL
(	NULL
64	NULL
)	NULL
,	NULL
STAT3	NULL
(	NULL
65	NULL
)	NULL
and	NULL
STATS	NULL
(	NULL
66	NULL
)	NULL
.	NULL

Since	NULL
our	NULL
results	NULL
derived	NULL
from	NULL
anti-STAT6	NULL
supershift	NULL
analysis	NULL
suggest	NULL
unique	NULL
STAT6	NULL
DNA-protein	NULL
complexes	NULL
,	NULL
we	NULL
hypothesize	NULL
that	NULL
these	NULL
distinct	NULL
complexes	NULL
may	NULL
represent	NULL
either	NULL
homodimeric	NULL
and	NULL
homotetrimeric	NULL
forms	NULL
of	NULL
STAT6	NULL
or	NULL
different	NULL
spliced	NULL
isoforms	NULL
of	NULL
STAT6	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
.	NULL

This	NULL
hypothesis	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
previous	NULL
observation	NULL
that	NULL
the	NULL
multiple	NULL
of	NULL
STAT6	NULL
mRNA	NULL
species	NULL
were	NULL
found	NULL
in	NULL
spleen	NULL
,	NULL
thymus	NULL
,	NULL
and	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
36	NULL
,	NULL
67	NULL
)	NULL
.	NULL

Thereby	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
distinct	NULL
splice	NULL
variants	NULL
of	NULL
STAT6	NULL
also	NULL
may	NULL
explain	NULL
a	NULL
putative	NULL
mechanism	NULL
by	NULL
which	NULL
IL-13	NULL
and	NULL
IL-4	NULL
can	NULL
differentially	NULL
signal	NULL
in	NULL
various	NULL
type	NULL
cells	NULL
,	NULL
such	NULL
as	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
in	NULL
our	NULL
study	NULL
,	NULL
with	NULL
different	NULL
biologic	NULL
effects	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
unclear	NULL
why	NULL
IL-13	NULL
and	NULL
IL-4	NULL
induce	NULL
similar	NULL
STAT6	NULL
DNA-binding	NULL
complexes	NULL
in	NULL
NK	NULL
cells	NULL
,	NULL
but	NULL
have	NULL
distinctive	NULL
effects	NULL
on	NULL
IFN-y	NULL
production	NULL
.	NULL

Nevertheless	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
other	NULL
signal	NULL
transduction	NULL
pathway	NULL
(	NULL
s	NULL
)	NULL
induced	NULL
by	NULL
IL-13	NULL
or	NULL
IL-4	NULL
also	NULL
might	NULL
be	NULL
involved	NULL
in	NULL
regulating	NULL
IFN-y	NULL
production	NULL
in	NULL
this	NULL
cell	NULL
type	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
IL-13	NULL
,	NULL
like	NULL
IL-4	NULL
,	NULL
can	NULL
directly	NULL
and	NULL
differentially	NULL
induce	NULL
STAT6	NULL
activation	NULL
in	NULL
freshly	NULL
isolated	NULL
primary	NULL
human	NULL
T	NULL
and	NULL
NK	NULL
cells	NULL
,	NULL
providing	NULL
new	NULL
evidence	NULL
that	NULL
these	NULL
cytokines	NULL
may	NULL
exert	NULL
cell-dependent	NULL
effects	NULL
on	NULL
primary	NULL
lymphocyte	NULL
populations	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
have	NULL
established	NULL
that	NULL
IL-13	NULL
has	NULL
a	NULL
unique	NULL
biologic	NULL
effect	NULL
on	NULL
the	NULL
modulation	NULL
of	NULL
IFN-y	NULL
secretion	NULL
,	NULL
cytolytic	NULL
potential	NULL
,	NULL
and	NULL
proliferation	NULL
of	NULL
primary	NULL
human	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
IL-13	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
NK	NULL
and	NULL
T	NULL
cell	NULL
biologic	NULL
activities	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Mr.	NULL
William	NULL
Bere	NULL
,	NULL
Ms.	NULL
Anna	NULL
Mason	NULL
,	NULL
and	NULL
Ms.	NULL
Robin	NULL
Winkler	NULL
Pickett	NULL
for	NULL
isolation	NULL
of	NULL
primary	NULL
human	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
and	NULL
ELISA	NULL
assays	NULL
.	NULL

We	NULL
also	NULL
are	NULL
grateful	NULL
to	NULL
Dr.	NULL
Andrew	NULL
Larner	NULL
(	NULL
Division	NULL
of	NULL
Cytokine	NULL
Biology	NULL
,	NULL
Center	NULL
for	NULL
Biologics	NULL
Evaluation	NULL
and	NULL
Research	NULL
,	NULL
FDA	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892	NULL
)	NULL
for	NULL
antisera	NULL
to	NULL
STAT1a	NULL
,	NULL
STAT3	NULL
,	NULL
STAT5a	NULL
,	NULL
and	NULL
STAT5b	NULL
,	NULL
and	NULL
for	NULL
helpful	NULL
discussions	NULL
,	NULL
and	NULL
Dr.	NULL
William	NULL
J.	NULL
LaRochelle	NULL
(	NULL
Laboratory	NULL
of	NULL
Cellular	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
NCI	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892	NULL
)	NULL
for	NULL
antiserum	NULL
to	NULL
STAT6	NULL
.	NULL

We	NULL
thank	NULL
Dr.Daniel	NULL
McVicar	NULL
for	NULL
critical	NULL
review	NULL
of	NULL
this	NULL
manuscript	NULL
.	NULL

We	NULL
also	NULL
are	NULL
grateful	NULL
to	NULL
Joyce	NULL
Vincent	NULL
and	NULL
Susan	NULL
Charbonneau	NULL
for	NULL
editorial	NULL
assistance	NULL
and	NULL
manuscript	NULL
preparation	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Ortaldo	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
and	NULL
R.	NULL
B.	NULL
Herberman	NULL
.	NULL

1984	NULL
.	NULL

Heterogeneity	NULL
of	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

2:359	NULL
.	NULL

2	NULL
.	NULL

Trinchieri	NULL
,	NULL
G.	NULL
1989	NULL
.	NULL

Biology	NULL
of	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

47:187	NULL
.	NULL

3	NULL
.	NULL

Paul	NULL
,	NULL
E.	NULL
W.	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Seder	NULL
.	NULL

1994	NULL
.	NULL

Lymphocyte	NULL
responses	NULL
and	NULL
cytokines	NULL
.	NULL

Cell	NULL
76:241	NULL
.	NULL

4	NULL
.	NULL

Minty	NULL
,	NULL
A.	NULL
,	NULL
P.	NULL
Chalon	NULL
,	NULL
J.-M.	NULL
Derocq	NULL
,	NULL
X.	NULL
Dumont	NULL
,	NULL
J.-C.	NULL
Gouillemot	NULL
,	NULL
M.	NULL
Kaghad	NULL
,	NULL
C.	NULL
Labit	NULL
,	NULL
P.	NULL
Leplatois	NULL
,	NULL
P.	NULL
Liauzun	NULL
,	NULL
B.	NULL
Miloux	NULL
,	NULL
C.	NULL
Minty	NULL
,	NULL
P.	NULL
Casellas	NULL
,	NULL
G.	NULL
Loison	NULL
,	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
226	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

J.	NULL
Lupker	NULL
,	NULL
P.	NULL
Ferrara	NULL
,	NULL
and	NULL
D.	NULL
Caput	NULL
.	NULL

1993	NULL
.	NULL

Interleukin-13	NULL
a	NULL
new	NULL
human	NULL
lymphokine	NULL
regulating	NULL
inflammatory	NULL
and	NULL
immune	NULL
response	NULL
.	NULL

Nature	NULL
362:248.	NULL
.	NULL

Zurawski	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
de	NULL
Vries	NULL
.	NULL

1994	NULL
.	NULL

Interleukin	NULL
13	NULL
,	NULL
an	NULL
interleukin	NULL
4-like	NULL
cytokine	NULL
that	NULL
acts	NULL
on	NULL
monocytes	NULL
and	NULL
B	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
on	NULL
T	NULL
cells	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
15:19.	NULL
.	NULL

Zurawki	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
F.	NULL
Vega	NULL
,	NULL
Jr.	NULL
,	NULL
B.	NULL
Huyghe	NULL
,	NULL
and	NULL
G.	NULL
Zurawski	NULL
.	NULL

1993	NULL
.	NULL

Receptors	NULL
for	NULL
interleukin-13	NULL
and	NULL
interleukin-4	NULL
cytokine	NULL
are	NULL
complex	NULL
and	NULL
share	NULL
a	NULL
novel	NULL
component	NULL
that	NULL
functions	NULL
in	NULL
signal	NULL
transduction	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:2663.	NULL
.	NULL

Debinski	NULL
,	NULL
W.	NULL
,	NULL
R.	NULL
Miner	NULL
,	NULL
P.	NULL
Leland	NULL
,	NULL
N.	NULL
I.	NULL
Obiri	NULL
,	NULL
and	NULL
R.	NULL
K.	NULL
Puri	NULL
.	NULL

1996	NULL
.	NULL

Receptor	NULL
for	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
13	NULL
does	NULL
not	NULL
interact	NULL
with	NULL
IL-4	NULL
but	NULL
receptor	NULL
for	NULL
IL-4	NULL
interacts	NULL
with	NULL
IL-13	NULL
on	NULL
human	NULL
glioma	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:22428.	NULL
.	NULL

Burd	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
W.	NULL
C.	NULL
Thompson	NULL
,	NULL
E.	NULL
E.	NULL
Max	NULL
,	NULL
and	NULL
F.	NULL
E.	NULL
Mills	NULL
.	NULL

1995	NULL
.	NULL

Activated	NULL
mast	NULL
cells	NULL
produce	NULL
interleukin	NULL
13	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181:1373.	NULL
.	NULL

Punnonen	NULL
,	NULL
J.	NULL
,	NULL
G.	NULL
Aversa	NULL
,	NULL
B.	NULL
G.	NULL
Cocks	NULL
,	NULL
A.	NULL
N.	NULL
J.	NULL
McKenzie	NULL
,	NULL
S.	NULL
Menon	NULL
,	NULL
G.	NULL
Zurawski	NULL
,	NULL
R.	NULL
de	NULL
Waal	NULL
Malefyt	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
de	NULL
.	NULL

Vries	NULL
.	NULL

1993	NULL
.	NULL

Interleukin	NULL
13	NULL
induces	NULL
interleukin	NULL
4-independent	NULL
IgG4	NULL
and	NULL
IgE	NULL
synthesis	NULL
and	NULL
CD23	NULL
expression	NULL
by	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:3730	NULL
.	NULL

Defrance	NULL
,	NULL
T.	NULL
,	NULL
P.	NULL
Carayon	NULL
,	NULL
G.	NULL
Billian	NULL
,	NULL
J-C.	NULL
Guillmot	NULL
,	NULL
A.	NULL
Minty	NULL
,	NULL
D.	NULL
Caput	NULL
,	NULL
and	NULL
P.	NULL
Ferrara	NULL
.	NULL

1994	NULL
.	NULL

Interleukin	NULL
13	NULL
is	NULL
a	NULL
B	NULL
cell	NULL
stimulating	NULL
factor	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179	NULL
;	NULL
135	NULL
.	NULL

Cocks	NULL
,	NULL
B.	NULL
G.	NULL
,	NULL
R.	NULL
de	NULL
Waal	NULL
Malefyt	NULL
,	NULL
J-P.	NULL
Galizzi	NULL
,	NULL
J.	NULL
E.	NULL
de	NULL
.	NULL

Vries	NULL
,	NULL
and	NULL
G.	NULL
Aversa	NULL
.	NULL

1993	NULL
.	NULL

IL-13	NULL
induces	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
human	NULL
B	NULL
cells	NULL
activated	NULL
by	NULL
the	NULL
CD40	NULL
ligand	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

5:657	NULL
.	NULL

Aversa	NULL
,	NULL
G.	NULL
,	NULL
J.	NULL
Punnonen	NULL
,	NULL
B.	NULL
G.	NULL
Cocks	NULL
,	NULL
R.	NULL
de	NULL
Waal	NULL
Malefyt	NULL
,	NULL
F.	NULL
Vega	NULL
,	NULL
F.	NULL
V.	NULL
Sandra	NULL
,	NULL
Jr.	NULL
,	NULL
S.	NULL
M.	NULL
Zyrawski	NULL
,	NULL
G.	NULL
Zurawski	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
de	NULL
.	NULL

Vries	NULL
.	NULL

1996	NULL
.	NULL

An	NULL
interleukin	NULL
4	NULL
(	NULL
IL-4	NULL
)	NULL
mutant	NULL
inhibits	NULL
both	NULL
IL-4	NULL
or	NULL
-13-induced	NULL
human	NULL
immunoglobulin	NULL
G4	NULL
(	NULL
IgG4	NULL
)	NULL
and	NULL
IgE	NULL
synthesis	NULL
and	NULL
B	NULL
cell	NULL
proliferation	NULL
:	NULL
support	NULL
for	NULL
a	NULL
common	NULL
component	NULL
shared	NULL
by	NULL
IL-4	NULL
and	NULL
IL-13	NULL
receptor	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:2213.	NULL
de	NULL
Waal	NULL
Malefyt	NULL
,	NULL
R.	NULL
,	NULL
J.	NULL
S.	NULL
Abrams	NULL
,	NULL
S.	NULL
M.	NULL
Zurawski	NULL
,	NULL
J-C.	NULL
Lecron	NULL
,	NULL
S.	NULL
Mohan-Peterson	NULL
,	NULL
B.	NULL
Sanjanwala	NULL
,	NULL
B.	NULL
Bennett	NULL
,	NULL
J	NULL
.	NULL

Silver	NULL
,	NULL
J.	NULL
E.	NULL
d.	NULL
Vries	NULL
,	NULL
and	NULL
H.	NULL
Yassel	NULL
.	NULL

1995	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
IL-13	NULL
and	NULL
IL-4	NULL
production	NULL
by	NULL
human	NULL
CD8	NULL
*	NULL
and	NULL
CD4*	NULL
ThO	NULL
,	NULL
Th1	NULL
and	NULL
Th2	NULL
T	NULL
cell	NULL
clones	NULL
and	NULL
EBE-transformed	NULL
B	NULL
cells	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

7:1405	NULL
.	NULL

Murata	NULL
,	NULL
T.	NULL
,	NULL
P.	NULL
D.	NULL
Noguchi	NULL
,	NULL
and	NULL
R.	NULL
K.	NULL
Puri	NULL
.	NULL

1996	NULL
.	NULL

Receptors	NULL
for	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-4	NULL
do	NULL
not	NULL
associate	NULL
with	NULL
the	NULL
common	NULL
gamma	NULL
chain	NULL
,	NULL
and	NULL
IL-4	NULL
induces	NULL
the	NULL
phosphorylation	NULL
of	NULL
JAK2	NULL
tyrosine	NULL
kinase	NULL
in	NULL
human	NULL
colon	NULL
carcinoma	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:30829	NULL
.	NULL

Obiri	NULL
,	NULL
N.	NULL
I.	NULL
,	NULL
W.	NULL
Debinski	NULL
,	NULL
W.	NULL
J.	NULL
Leonard	NULL
,	NULL
and	NULL
R.	NULL
K.	NULL
Puri	NULL
.	NULL

1995	NULL
.	NULL

Receptor	NULL
for	NULL
IL-13	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:8797	NULL
.	NULL

Kohler	NULL
,	NULL
I.	NULL
,	NULL
P.	NULL
Alliger	NULL
,	NULL
A.	NULL
Minty	NULL
,	NULL
D.	NULL
Caput	NULL
,	NULL
P.	NULL
Ferrara	NULL
,	NULL
Holl-Neugebauer	NULL
,	NULL
B.	NULL
,	NULL
G.	NULL
Rank	NULL
,	NULL
and	NULL
E.	NULL
P.	NULL
Ricber	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
interleukin-13	NULL
activates	NULL
the	NULL
interleukin-4-dependent	NULL
transcription	NULL
factor	NULL
NF-IL-4	NULL
sharing	NULL
a	NULL
DNA	NULL
binding	NULL
motif	NULL
with	NULL
an	NULL
interferon-	NULL
(	NULL
-induced	NULL
nuclear	NULL
binding	NULL
factor	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

345:187	NULL
.	NULL

Lin	NULL
,	NULL
J-X	NULL
.	NULL

,	NULL
T-S.	NULL
Migone	NULL
,	NULL
M.	NULL
Tsang	NULL
,	NULL
M.	NULL
Griedman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Weatherbee	NULL
,	NULL
L.	NULL
Zhou	NULL
,	NULL
A.	NULL
Yamauchi	NULL
,	NULL
E.	NULL
T.	NULL
Bloom	NULL
,	NULL
J.	NULL
Mictz	NULL
,	NULL
S.	NULL
John	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
role	NULL
of	NULL
shared	NULL
receptor	NULL
motif	NULL
and	NULL
common	NULL
Stat	NULL
protein	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
cytokine	NULL
pleiotropy	NULL
and	NULL
redundancy	NULL
by	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-7	NULL
,	NULL
IL-13	NULL
,	NULL
and	NULL
IL-15	NULL
.	NULL

Immunity	NULL
2:231	NULL
.	NULL

Kishimoto	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Taga	NULL
,	NULL
and	NULL
S.	NULL
Akira	NULL
.	NULL

1994	NULL
.	NULL

Cytokine	NULL
signal	NULL
transduction	NULL
.	NULL

Cell	NULL
76:253	NULL
.	NULL

Zurawski	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
P.	NULL
Chomara	NULL
,	NULL
O.	NULL
Djosson	NULL
,	NULL
C.	NULL
Bidaud	NULL
,	NULL
A.	NULL
N.	NULL
J.	NULL
McKenzie	NULL
,	NULL
P.	NULL
Miossec	NULL
,	NULL
J.	NULL
Banchereau	NULL
,	NULL
and	NULL
G.	NULL
Zurawski	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
primary	NULL
binding	NULL
subunit	NULL
of	NULL
the	NULL
human	NULL
interleukin-4	NULL
receptor	NULL
is	NULL
also	NULL
a	NULL
component	NULL
of	NULL
the	NULL
interleukin-13	NULL
receptor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:13869	NULL
.	NULL

Smerz-Bertling	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
A.	NULL
Duschi	NULL
.	NULL

1995	NULL
.	NULL

Both	NULL
interleukin	NULL
4	NULL
and	NULL
interleukin	NULL
13	NULL
induce	NULL
tyrosine	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:966	NULL
.	NULL

Malabarba	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
H.	NULL
Rui	NULL
,	NULL
H.	NULL
H.	NULL
J.	NULL
Deutsch	NULL
,	NULL
J.	NULL
Chung	NULL
,	NULL
F.	NULL
S.	NULL
Kalthoff	NULL
,	NULL
W.	NULL
L.	NULL
Farrar	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Kirken	NULL
.	NULL

1996	NULL
.	NULL

Interleukin-13	NULL
is	NULL
a	NULL
potent	NULL
activator	NULL
of	NULL
JAK3	NULL
and	NULL
STAT6	NULL
in	NULL
cells	NULL
expressing	NULL
interleukin-2	NULL
receptor-y	NULL
and	NULL
interleukin-4	NULL
recep-tor-a	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

319:865	NULL
.	NULL

Malabarba	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
R.	NULL
A.	NULL
Kirken	NULL
,	NULL
H.	NULL
Rui	NULL
,	NULL
K.	NULL
Koctinitz	NULL
,	NULL
M.	NULL
Kawamura	NULL
,	NULL
J.	NULL
J.	NULL
O'Shea	NULL
,	NULL
F.	NULL
S.	NULL
Kalthoff	NULL
,	NULL
and	NULL
W.	NULL
L.	NULL
Farrar	NULL
.	NULL

1995	NULL
.	NULL

Activation	NULL
of	NULL
JAK3	NULL
,	NULL
but	NULL
not	NULL
JAK1	NULL
,	NULL
is	NULL
critical	NULL
to	NULL
interleukin-4	NULL
(	NULL
IL-4	NULL
)	NULL
stimulated	NULL
proliferation	NULL
and	NULL
requires	NULL
a	NULL
membrane-proximal	NULL
region	NULL
of	NULL
IL-4Ra	NULL
«	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:9630	NULL
.	NULL

Takeda	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
Kamanaka	NULL
,	NULL
T.	NULL
Tanaka	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
and	NULL
S.	NULL
Akira	NULL
.	NULL

1996	NULL
.	NULL

Impaired	NULL
IL-13-mediated	NULL
functions	NULL
of	NULL
macrophages	NULL
on	NULL
STAT6-deficient	NULL
mice	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:3220	NULL
.	NULL

Kotowicz	NULL
,	NULL
K.	NULL
,	NULL
R.	NULL
E.	NULL
Callard	NULL
,	NULL
K.	NULL
Friedrich	NULL
,	NULL
D.	NULL
J.	NULL
Matthews	NULL
,	NULL
and	NULL
N.	NULL
Klein	NULL
.	NULL

1996	NULL
.	NULL

Biological	NULL
activity	NULL
of	NULL
IL-4	NULL
and	NULL
IL-13	NULL
on	NULL
human	NULL
endothelial	NULL
cells	NULL
:	NULL
functional	NULL
evidence	NULL
that	NULL
both	NULL
cytokines	NULL
act	NULL
through	NULL
the	NULL
same	NULL
receptor	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

8:1915	NULL
.	NULL

Takeshita	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Asso	NULL
,	NULL
K.	NULL
Ohtani	NULL
,	NULL
N.	NULL
Ishii	NULL
,	NULL
S.	NULL
Kumaki	NULL
,	NULL
N.	NULL
Tanaka	NULL
,	NULL
H.	NULL
Munakata	NULL
,	NULL
M.	NULL
Najamura	NULL
,	NULL
and	NULL
K.	NULL
Sugamura	NULL
.	NULL

1992	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
gamma	NULL
chain	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
receptor	NULL
.	NULL

Science	NULL
257:379	NULL
.	NULL

Kondo	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
Takeshita	NULL
,	NULL
N.	NULL
Ishii	NULL
,	NULL
M.	NULL
Nakamura	NULL
,	NULL
S.	NULL
Watanabe	NULL
,	NULL
K-L	NULL
Arai	NULL
,	NULL
and	NULL
K.	NULL
Sugamura	NULL
.	NULL

1993	NULL
.	NULL

Sharing	NULL
of	NULL
the	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
receptor	NULL
gamma	NULL
chain	NULL
between	NULL
receptors	NULL
for	NULL
IL-2	NULL
and	NULL
IL-4	NULL
.	NULL

Science	NULL
262:1874	NULL
.	NULL

Miyazaki	NULL
,	NULL
T.	NULL
,	NULL
A.	NULL
Kawahara	NULL
,	NULL
H.	NULL
Fujii	NULL
,	NULL
Y.	NULL
Nakagawa	NULL
,	NULL
Y.	NULL
Minami	NULL
,	NULL
Z-J	NULL
.	NULL

Liu	NULL
,	NULL
I.	NULL
Oishi	NULL
,	NULL
O.	NULL
Silvennoinen	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Witthuhn	NULL
,	NULL
J.	NULL
N.	NULL
Thie	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1994	NULL
.	NULL

Functional	NULL
activation	NULL
of	NULL
Jak1	NULL
and	NULL
Jak3	NULL
by	NULL
selective	NULL
association	NULL
with	NULL
IL-2	NULL
receptor	NULL
subunits	NULL
.	NULL

Science	NULL
266:1045	NULL
.	NULL

Hilton	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
J-G.	NULL
Zhang	NULL
,	NULL
D.	NULL
Metcalf	NULL
,	NULL
W.	NULL
S.	NULL
Alexander	NULL
,	NULL
N.	NULL
A.	NULL
Nicola	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Willson	NULL
.	NULL

1996	NULL
.	NULL

Cloning	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
binding	NULL
subunit	NULL
of	NULL
the	NULL
interleukin	NULL
13	NULL
receptor	NULL
that	NULL
is	NULL
also	NULL
a	NULL
component	NULL
of	NULL
the	NULL
interleukin	NULL
4	NULL
receptor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:497	NULL
.	NULL

Caput	NULL
,	NULL
D.	NULL
,	NULL
P.	NULL
Laurent	NULL
,	NULL
M.	NULL
Kaghad	NULL
,	NULL
J.-M.	NULL
Lelias	NULL
,	NULL
S.	NULL
Lefort	NULL
,	NULL
N.	NULL
Vita	NULL
,	NULL
and	NULL
P.	NULL
Ferrara	NULL
.	NULL

1996	NULL
.	NULL

Cloning	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
specific	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-13	NULL
binding	NULL
protein	NULL
structurally	NULL
related	NULL
to	NULL
the	NULL
IL-5	NULL
receptor	NULL
a	NULL
chain	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:16921	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

EFFECTS	NULL
OF	NULL
IL-13	NULL
ON	NULL
NK	NULL
AND	NULL
T	NULL
CELLS	NULL
Aman	NULL
,	NULL
M.	NULL
J	NULL
,	NULL
N.	NULL
Tayebi	NULL
,	NULL
N.	NULL
I.	NULL
Obiri	NULL
,	NULL
M.	NULL
S.	NULL
Modi	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1996.	NULL
cDNA	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
human	NULL
interleukin	NULL
13	NULL
receptor	NULL
a	NULL
chain	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:29265	NULL
.	NULL

Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
I.	NULL
M.	NULL
Kerr	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Stark	NULL
.	NULL

1994	NULL
.	NULL

Jak-STAT	NULL
pathways	NULL
and	NULL
transcriptional	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
IFNs	NULL
and	NULL
other	NULL
extracellular	NULL
signaling	NULL
proteins	NULL
.	NULL

Science	NULL
264:1416	NULL
.	NULL

Thie	NULL
,	NULL
J.	NULL
N.	NULL
1995	NULL
.	NULL

Cytokine	NULL
receptor	NULL
signaling	NULL
.	NULL

Nature	NULL
377:591	NULL
.	NULL

Taniguchi	NULL
,	NULL
T.	NULL
1995	NULL
.	NULL

Cytokine	NULL
signaling	NULL
through	NULL
nonreceptor	NULL
protein	NULL
tyrosine	NULL
ki-nases	NULL
.	NULL

Science	NULL
268:251	NULL
.	NULL

Russell	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Johnston	NULL
,	NULL
M.	NULL
Noguchi	NULL
,	NULL
M.	NULL
Kawamura	NULL
,	NULL
C.	NULL
M.	NULL
Bacon	NULL
,	NULL
M.	NULL
Friendmann	NULL
,	NULL
M.	NULL
Berg	NULL
,	NULL
D.	NULL
W.	NULL
McVicar	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Witthuhn	NULL
,	NULL
O.	NULL
Silvennoinen	NULL
,	NULL
A.	NULL
S.	NULL
Goldman	NULL
,	NULL
F.	NULL
C.	NULL
Schmalstieg	NULL
,	NULL
J.	NULL
N.	NULL
Thle	NULL
,	NULL
J.	NULL
J.	NULL
O'Shea	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1994	NULL
.	NULL

Interaction	NULL
of	NULL
IL-2R	NULL
$	NULL
and	NULL
yc	NULL
chains	NULL
with	NULL
Jak1	NULL
and	NULL
Jak3	NULL
:	NULL
implications	NULL
for	NULL
XSCID	NULL
and	NULL
XCID	NULL
.	NULL

Science	NULL
266:1042	NULL
.	NULL

Kotanides	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
N.	NULL
C.	NULL
Reich	NULL
.	NULL

1993	NULL
.	NULL

Requirement	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
for	NULL
rapid	NULL
activation	NULL
of	NULL
a	NULL
DNA	NULL
binding	NULL
factor	NULL
by	NULL
IL-4	NULL
.	NULL

Science	NULL
262:1265	NULL
.	NULL

Hou	NULL
,	NULL
J.	NULL
,	NULL
U.	NULL
Schindler	NULL
,	NULL
W.	NULL
J.	NULL
Henzel	NULL
,	NULL
T-C.	NULL
Ho	NULL
,	NULL
M.	NULL
Brasseur	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1994	NULL
.	NULL

An	NULL
-	NULL
interleukin-4-induced	NULL
transcription	NULL
factor	NULL
:	NULL
IL-4	NULL
Stat	NULL
.	NULL

Science	NULL
265:17014	NULL
.	NULL

Ryan	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
L.	NULL
C.	NULL
McReynolds	NULL
,	NULL
A.	NULL
Keegan	NULL
,	NULL
L-H.	NULL
Wang	NULL
,	NULL
E.	NULL
Garfein	NULL
,	NULL
P.	NULL
Rothman	NULL
,	NULL
K.	NULL
Nelms	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1996	NULL
.	NULL

Growth	NULL
and	NULL
gene	NULL
expression	NULL
are	NULL
predominantly	NULL
controlled	NULL
by	NULL
distinct	NULL
regions	NULL
of	NULL
the	NULL
human	NULL
IL-4	NULL
receptor	NULL
.	NULL

Immunity	NULL
4:123	NULL
.	NULL

Wang	NULL
,	NULL
H.	NULL
Y.	NULL
,	NULL
W.	NULL
E.	NULL
Paul	NULL
,	NULL
and	NULL
A.	NULL
D.	NULL
Keegan	NULL
.	NULL

1996	NULL
.	NULL

IL-4	NULL
function	NULL
can	NULL
be	NULL
transferred	NULL
to	NULL
the	NULL
IL-2	NULL
receptor	NULL
by	NULL
tyrosine	NULL
containing	NULL
sequences	NULL
found	NULL
in	NULL
the	NULL
IL-4	NULL
receptor	NULL
a	NULL
chain	NULL
.	NULL

Immunity	NULL
4:113	NULL
.	NULL

Lai	NULL
,	NULL
S.	NULL
Y.	NULL
,	NULL
J.	NULL
Molden	NULL
,	NULL
K.	NULL
D.	NULL
Liu	NULL
,	NULL
J.	NULL
M.	NULL
Puck	NULL
,	NULL
M.	NULL
D.	NULL
White	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Goldsmith	NULL
.	NULL

1996	NULL
.	NULL

Interleukin-4-specific	NULL
signal	NULL
transduction	NULL
events	NULL
are	NULL
driven	NULL
by	NULL
homotypic	NULL
interaction	NULL
of	NULL
the	NULL
interleukin-4	NULL
receptor	NULL
a	NULL
chain	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:4506	NULL
.	NULL

Oakes	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
F.	NULL
Candotti	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Johnston	NULL
,	NULL
Y-Q	NULL
.	NULL

Chen	NULL
,	NULL
J.	NULL
J.	NULL
Ryan	NULL
,	NULL
N.	NULL
Taylor	NULL
,	NULL
X.	NULL
Liu	NULL
,	NULL
L.	NULL
Hennighausen	NULL
,	NULL
L.	NULL
D.	NULL
Notarangelo	NULL
,	NULL
W.	NULL
E.	NULL
Paul	NULL
,	NULL
R.	NULL
M.	NULL
Blaese	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
O'Shea	NULL
.	NULL

1996	NULL
.	NULL

Signaling	NULL
via	NULL
IL-2	NULL
and	NULL
IL-4	NULL
in	NULL
JAK3-deficient	NULL
severe	NULL
combined	NULL
immunodeficiency	NULL
lymphocytes	NULL
:	NULL
JAK3-dependent	NULL
and	NULL
independent	NULL
pathways	NULL
.	NULL

Immunity	NULL
5:605	NULL
.	NULL

Taketa	NULL
,	NULL
K.	NULL
,	NULL
T.	NULL
Tanaka	NULL
,	NULL
W.	NULL
Shi	NULL
,	NULL
M.	NULL
Matsumoto	NULL
,	NULL
S-L	NULL
Kashiwamura	NULL
,	NULL
K.	NULL
Nakanishi	NULL
,	NULL
N.	NULL
Yoshida	NULL
,	NULL
T.	NULL
Kishmoto	NULL
,	NULL
and	NULL
S.	NULL
Akira	NULL
.	NULL

1996	NULL
.	NULL

Essential	NULL
role	NULL
of	NULL
STAT6	NULL
on	NULL
IL-4	NULL
signaling	NULL
.	NULL

Nature	NULL
380:627	NULL
.	NULL

Shimoda	NULL
,	NULL
K.	NULL
,	NULL
J.	NULL
v.	NULL
Deursen	NULL
,	NULL
M.	NULL
Y.	NULL
Sangster	NULL
,	NULL
S.	NULL
R.	NULL
Sarawar	NULL
,	NULL
R.	NULL
T.	NULL
Carson	NULL
,	NULL
R.	NULL
A.	NULL
Tripp	NULL
,	NULL
C.	NULL
Chu	NULL
,	NULL
F.	NULL
W.	NULL
Quelle	NULL
,	NULL
T.	NULL
Nosaka	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

A.	NULL
Vignali	NULL
,	NULL
P.	NULL
C.	NULL
Doherty	NULL
,	NULL
G.	NULL
Grosveld	NULL
,	NULL
W.	NULL
E.	NULL
Paul	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Ihle	NULL
.	NULL

1996	NULL
.	NULL

Lack	NULL
of	NULL
IL-4-induced	NULL
Th2	NULL
response	NULL
and	NULL
IgE	NULL
class	NULL
switching	NULL
in	NULL
mice	NULL
with	NULL
disrupted	NULL
Stat6	NULL
gene	NULL
.	NULL

Nature	NULL
380:630	NULL
.	NULL

Kaplan	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
U.	NULL
Schindler	NULL
,	NULL
S.	NULL
T.	NULL
Smiley	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Grusby	NULL
.	NULL

1996	NULL
.	NULL

STAT6	NULL
is	NULL
required	NULL
for	NULL
mediating	NULL
responses	NULL
to	NULL
IL-4	NULL
and	NULL
for	NULL
the	NULL
development	NULL
of	NULL
Th2	NULL
cells	NULL
.	NULL

Immunity	NULL
4:313	NULL
.	NULL

Patel	NULL
,	NULL
B.	NULL
K.	NULL
R.	NULL
,	NULL
L-M.	NULL
Wang	NULL
,	NULL
C-C.	NULL
Lee	NULL
,	NULL
W.	NULL
G.	NULL
Taylor	NULL
,	NULL
J.	NULL
H.	NULL
Pierce	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
LaRochelle	NULL
.	NULL

1996	NULL
.	NULL

Staté	NULL
and	NULL
Jak1	NULL
are	NULL
common	NULL
elements	NULL
in	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
and	NULL
interleukin-4	NULL
signal	NULL
transduction	NULL
pathways	NULL
in	NULL
NIH	NULL
3T3	NULL
fibro-blasts	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:22175	NULL
.	NULL

Timomen	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
R.	NULL
Ortaldo	NULL
,	NULL
and	NULL
R.	NULL
B.	NULL
Herberman	NULL
.	NULL

1981	NULL
.	NULL

Characteristics	NULL
of	NULL
human	NULL
large	NULL
granular	NULL
lymphocytes	NULL
and	NULL
relationship	NULL
to	NULL
natural	NULL
killer	NULL
and	NULL
K	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

153:569	NULL
.	NULL

Smyth	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Ortaldo	NULL
.	NULL

1991	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
IL-2	NULL
and	NULL
IL-6	NULL
on	NULL
the	NULL
lytic	NULL
activity	NULL
of	NULL
purified	NULL
human	NULL
peripheral	NULL
blood	NULL
large	NULL
granular	NULL
lympho-cytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:1380	NULL
.	NULL

Lozzi	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
and	NULL
B	NULL
.	NULL

B.	NULL
Lozzi	NULL
.	NULL

1975	NULL
.	NULL

Human	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
cell	NULL
line	NULL
with	NULL
positive	NULL
philadelphia	NULL
.	NULL

Blood	NULL
45:321	NULL
.	NULL

Mason	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
S.	NULL
K.	NULL
Anderson	NULL
,	NULL
W.	NULL
M.	NULL
Yokoyama	NULL
,	NULL
H.	NULL
R.	NULL
C.	NULL
Smith	NULL
,	NULL
R.	NULL
Winkler-Pickett	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Ortaldo	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
Ly-49D	NULL
receptor	NULL
activates	NULL
murine	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:2119	NULL
.	NULL

Yu	NULL
,	NULL
C-R.	NULL
,	NULL
J-X	NULL
.	NULL

Lin	NULL
,	NULL
D.	NULL
W.	NULL
Fink	NULL
,	NULL
S.	NULL
Akira	NULL
,	NULL
E.	NULL
T.	NULL
Bloom	NULL
,	NULL
and	NULL
A.	NULL
Yamauchi	NULL
.	NULL

1996	NULL
.	NULL

Differential	NULL
utilization	NULL
of	NULL
Janus	NULL
kinase-signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
signal	NULL
pathways	NULL
in	NULL
the	NULL
stimulation	NULL
of	NULL
human	NULL
natural	NULL
killer	NULL
cells	NULL
by	NULL
IL-2	NULL
,	NULL
IL-12	NULL
,	NULL
and	NULL
IFN-	NULL
@	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:126	NULL
.	NULL

Rothman	NULL
,	NULL
P.	NULL
,	NULL
S.	NULL
C.	NULL
Li	NULL
,	NULL
L.	NULL
Gorham	NULL
,	NULL
F.	NULL
Alt	NULL
,	NULL
and	NULL
M.	NULL
Boothby	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
conserved	NULL
lipopolysaccharide-plus-interleukin-4-responsive	NULL
element	NULL
located	NULL
at	NULL
the	NULL
promoter	NULL
of	NULL
germ	NULL
line	NULL
e	NULL
transcripts	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:5551	NULL
.	NULL

Wagner	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
T.	NULL
E.	NULL
Hayes	NULL
,	NULL
C.	NULL
J.	NULL
Hoban	NULL
,	NULL
and	NULL
B.	NULL
H.	NULL
Cochran	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
SIE	NULL
binding	NULL
element	NULL
confers	NULL
sis/PDGF	NULL
inducibility	NULL
onto	NULL
the	NULL
c-fos	NULL
promoter	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:4477	NULL
.	NULL

Sadowski	NULL
,	NULL
H.	NULL
B.	NULL
,	NULL
K.	NULL
Shuai	NULL
,	NULL
J.	NULL
E.	NULL
Darnell	NULL
,	NULL
and	NULL
M.	NULL
Z.	NULL
Giman	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
common	NULL
nuclear	NULL
signal	NULL
transduction	NULL
pathway	NULL
activated	NULL
by	NULL
growth	NULL
factor	NULL
and	NULL
cytokine	NULL
receptor	NULL
.	NULL

Science	NULL
261:1739	NULL
.	NULL

Nagler	NULL
,	NULL
A.	NULL
,	NULL
L.	NULL
L.	NULL
Lanier	NULL
,	NULL
and	NULL
J.	NULL
H.	NULL
Phillips	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
IL-4	NULL
on	NULL
human	NULL
natural	NULL
killer	NULL
cells	NULL
,	NULL
a	NULL
potent	NULL
regulator	NULL
of	NULL
IL-2	NULL
activation	NULL
and	NULL
proliferation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

141:2349	NULL
.	NULL

Kawakami	NULL
,	NULL
Y.	NULL
,	NULL
M.	NULL
C.	NULL
Custer	NULL
,	NULL
S.	NULL
A.	NULL
Rosenberg	NULL
,	NULL
and	NULL
M.	NULL
T.	NULL
Lotze	NULL
.	NULL

1989	NULL
.	NULL

IL-4	NULL
regulates	NULL
IL-2	NULL
induction	NULL
of	NULL
lymphokine-activated	NULL
killer	NULL
activity	NULL
from	NULL
human	NULL
lym-phocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

142:3452	NULL
.	NULL

Vercelli	NULL
,	NULL
D.	NULL
,	NULL
H.	NULL
H.	NULL
Jabara	NULL
,	NULL
R.	NULL
P.	NULL
Lauener	NULL
,	NULL
and	NULL
R.	NULL
S.	NULL
Geha	NULL
.	NULL

1990	NULL
.	NULL

IL-4	NULL
inhibits	NULL
the	NULL
synthesis	NULL
of	NULL
IFN-y	NULL
and	NULL
induces	NULL
the	NULL
synthesis	NULL
of	NULL
IgB	NULL
in	NULL
human	NULL
mixed	NULL
lymphocyte	NULL
culture	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:570	NULL
.	NULL

Brown	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
Hu-Li	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1988	NULL
.	NULL

IL-4/B	NULL
cell	NULL
stimulatory	NULL
factor	NULL
1	NULL
stimulates	NULL
T	NULL
cell	NULL
growth	NULL
by	NULL
an	NULL
IL-2-independent	NULL
mechanism	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

131	NULL
:	NULL
504	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

Martinez	NULL
,	NULL
O.	NULL
M.	NULL
,	NULL
R.	NULL
S.	NULL
Gibbons	NULL
,	NULL
M.	NULL
R.	NULL
Garvin	NULL
,	NULL
and	NULL
F.	NULL
R.	NULL
Aronson	NULL
.	NULL

1990	NULL
.	NULL

IL-4	NULL
inhibits	NULL
IL-2	NULL
receptor	NULL
expression	NULL
and	NULL
IL-2-dependent	NULL
proliferation	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:2211	NULL
.	NULL

Thile	NULL
,	NULL
J.	NULL
N.	NULL
1996	NULL
.	NULL

STATs	NULL
:	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
.	NULL

Cell	NULL
84:331	NULL
.	NULL

Zhong	NULL
,	NULL
Z.	NULL
,	NULL
Z.	NULL
Wen	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Darnell	NULL
.	NULL

1994	NULL
.	NULL

Stat3	NULL
:	NULL
STAT	NULL
family	NULL
member	NULL
activated	NULL
by	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
response	NULL
to	NULL
epidermal	NULL
growth	NULL
factor	NULL
and	NULL
interleukin-6	NULL
.	NULL

Science	NULL
264:95	NULL
.	NULL

Zhang	NULL
,	NULL
X.	NULL
,	NULL
J.	NULL
Blenis	NULL
,	NULL
H-C.	NULL
Li	NULL
,	NULL
C.	NULL
Schindler	NULL
,	NULL
S.	NULL
Chen-Kiang	NULL
.	NULL

1995	NULL
.	NULL

Requirement	NULL
of	NULL
serine	NULL
phosphorylation	NULL
for	NULL
formation	NULL
of	NULL
STAT-promoter	NULL
complexes	NULL
.	NULL

Science	NULL
267:1990	NULL
.	NULL

Nakayuki	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
Blenis	NULL
,	NULL
H-C.	NULL
Li	NULL
,	NULL
C.	NULL
Schlinder	NULL
,	NULL
S.	NULL
Chen-Kiang	NULL
.	NULL

1995	NULL
.	NULL

Requirement	NULL
of	NULL
serine	NULL
phosphorylation	NULL
for	NULL
formation	NULL
of	NULL
STAT-promoter	NULL
complexes	NULL
.	NULL

Science	NULL
267:1990	NULL
.	NULL

Keegan	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Johnston	NULL
,	NULL
P.	NULL
J.	NULL
Tortolani	NULL
,	NULL
L.	NULL
J.	NULL
McReynolds	NULL
,	NULL
C.	NULL
Kinzer	NULL
,	NULL
J.	NULL
J.	NULL
O'Shea	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1995	NULL
.	NULL

Similarities	NULL
and	NULL
differences	NULL
in	NULL
signaling	NULL
transduction	NULL
by	NULL
interleukin-4	NULL
and	NULL
interleukin-13	NULL
:	NULL
analysis	NULL
of	NULL
Janus	NULL
kinase	NULL
activation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:7681	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

227	NULL
Rolling	NULL
,	NULL
C.	NULL
,	NULL
D.	NULL
Treton	NULL
,	NULL
S.	NULL
Pellegrini	NULL
,	NULL
P.	NULL
Galanaud	NULL
,	NULL
and	NULL
Y.	NULL
Richard	NULL
.	NULL

1996	NULL
.	NULL

IL-4	NULL
and	NULL
TL-13	NULL
receptors	NULL
share	NULL
the	NULL
gamma	NULL
chain	NULL
and	NULL
activate	NULL
STAT6	NULL
,	NULL
STAT3	NULL
and	NULL
STATS	NULL
proteins	NULL
in	NULL
normal	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

FEBS	NULL
Left	NULL
.	NULL

393:53	NULL
.	NULL

Fu	NULL
,	NULL
X.-Y	NULL
.	NULL

,	NULL
C.	NULL
Schindler	NULL
,	NULL
T.	NULL
Improta	NULL
,	NULL
R.	NULL
Aebersold	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Darnell	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
proteins	NULL
of	NULL
ISGF-3	NULL
,	NULL
the	NULL
interferon	NULL
-induced	NULL
transcriptional	NULL
activator	NULL
,	NULL
define	NULL
a	NULL
gene	NULL
family	NULL
involved	NULL
in	NULL
signal	NULL
transduction	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:7840	NULL
.	NULL

Schaefer	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
L.	NULL
K.	NULL
Sanders	NULL
,	NULL
and	NULL
D.	NULL
Nathans	NULL
.	NULL

1995	NULL
.	NULL

Cooperative	NULL
transcriptional	NULL
activity	NULL
of	NULL
Jun	NULL
and	NULL
Stat3	NULL
$	NULL
,	NULL
a	NULL
short	NULL
form	NULL
of	NULL
STAT3	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:9097	NULL
.	NULL

Wang	NULL
,	NULL
D.	NULL
,	NULL
D.	NULL
Stravopodis	NULL
,	NULL
S.	NULL
Teglund	NULL
,	NULL
J.	NULL
Kitazawa	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Ihle	NULL
.	NULL

1996	NULL
.	NULL

Naturally	NULL
occurring	NULL
dominant	NULL
negative	NULL
variants	NULL
of	NULL
Stat5	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
:	NULL
6141	NULL
.	NULL

Jaso-Friedmann	NULL
,	NULL
L.	NULL
,	NULL
J.	NULL
H.	NULL
Leary	NULL
,	NULL
III	NULL
,	NULL
and	NULL
D.	NULL
L.	NULL
Evans	NULL
.	NULL

1994	NULL
.	NULL

Pathways	NULL
of	NULL
signaling	NULL
in	NULL
nonspecific	NULL
cytotoxic	NULL
cells	NULL
:	NULL
effects	NULL
of	NULL
protein	NULL
kinase	NULL
and	NULL
phosphatase	NULL
in	NULL
hibitors	NULL
and	NULL
evidence	NULL
for	NULL
membrane	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

153:142	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL

